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Abstract 
The development of diagnostic technics for early detection of cardiovascular risk 
factors allows the anticipated treatment of the cardiac diseases, increasing the survival 
probability. The cardiac output monitoring by invasive methods have been one standard 
criterion for the evaluation of hemodynamics. In this context, the Impedance Cardiography 
technic appears as a simple, non-invasive and cost-effective alternative to monitor relative 
changes in the cardiac output, as well systolic time intervals. 
An Impedance Cardiography system prototype was developed based on the AD5933-
integrated impedance meter, adapted to perform in a tetrapolar electrode configuration while 
allowing the injection of a safe excitation current into the subject and sensing the voltage 
differential generated to assess the thoracic impedance value. The synchronous 
Electrocardiogram register was also tested. For the control of the system operation the 
firmware running on an Arduino® microcontroller board and the graphical user interface based 
on Matlab® were developed.  
The results of the system performance evaluation, including the validation tests 
performed on volunteers to assess relevant physiological parameters are presented, as well as 
the abbreviated signal analysis methodology applied. 
 
Keywords 
Electrical bioimpedance, Impedance Cardiography, Cardiac Output, AD5933, Arduino. 
  
 iv 
 
 
  
 v 
 
Resumo 
O desenvolvimento de técnicas de diagnóstico para deteção prematura de fatores de 
risco cardiovascular permite o tratamento antecipado das doenças cardíacas, aumentando a 
probabilidade de sobrevivência. A monitorização do débito cardíaco com base em métodos 
invasivos tem sido um padrão para avaliação hemodinâmica. Neste contexto, a técnica de 
Cardiografia de Impedância surge como uma alternativa simples, não-invasiva e de baixo custo 
que permite monitorizar variações do débito cardíaco, assim como determinar os tempos 
sistólicos. 
Foi desenvolvido um protótipo para realização de Cardiografia de Impedância 
baseado num impedancímetro integrado, o AD5933, adaptando-o para operar numa 
configuração tetrapolar, de modo a injetar uma corrente de excitação controlada no sujeito e 
medir a diferença de potencial elétrico gerada, para obter o valor de impedância torácica. A 
recolha paralela do sinal de Eletrocardiograma foi também testada. Para controlar a operação 
do sistema foram desenvolvidos o firmware, que corre numa placa Arduino®, e a interface 
gráfica baseada em Matlab®. 
São apresentados os resultados da avaliação de performance do sistema, incluindo 
os testes de validação realizados em voluntários para obter parâmetros com relevância 
fisiológica, assim como a descrição da metodologia aplicada à análise dos sinais recolhidos. 
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1.1.  Introduction 
The characteristic electrical impedance of a biological tissue depends on its structure 
and composition and the variation of such parameters over time reflects itself on the 
impedance value. 
Impedance Cardiography studies the impedance changes in the human chest cavity, 
arising from volumetric variations of fluids, mostly related to blood translocations during the 
cardiac cycle. It presents a non-invasive option to continuously monitoring hemodynamic 
parameters, such as systolic time intervals and cardiac volumes. 
 
1.2. Motivation 
According to the World Health Organization, cardiovascular diseases are the number 
one cause of death worldwide and are expected to remain in the future. The development of 
diagnostic technics for early detection of cardiovascular risk factors that allow the anticipated 
treatment can lead to higher survival rates.  
The evaluation of the hemodynamic state of the patients in clinical emergency 
environments is required. The standard vital signs monitored in every medical procedure are 
heart rate, blood pressure, respiration rate and body temperature [1]. After the pulse oximetry 
proved to be a fit fifth vital sign, other authors considered the cardiac output from Impedance 
Cardiography (ICG) appropriated to be used as the next vital sign [2]. 
In this context, the cardiac output obtained by thermodilution has been a standard 
parameter for hemodynamic evaluation. Nevertheless, such method is invasive, expensive and 
time-consuming. Patient comfort, simplicity and cost-effectiveness are desirable 
characteristics presented by the Impedance Cardiography technic, that exhibits the potential 
to monitor relative changes in the cardiac output, providing long-term continuous monitoring 
of the myocardial contractility, as well reliable systolic time intervals [3]. 
The impedance measurement, although, is affected by several distinct factors, which 
increase the complexity of its interpretation and difficult the reliable quantification of isolated 
physiological parameters, imposing restrictions on its use. Despite the ICG’s current use in 
clinical environment, certain points still need to be addressed in what concerns with the 
methodological standardization, improvement of signal processing methods to eliminate non-
blood related effects, validation of realistic chest models applied to calculate hemodynamic 
parameters, reduce the uncertainties of blood resistivity estimation [4, 5], as well as the 
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acquaintance of the ICG signal source. On this basis, the interpretations of impedance 
cardiographic information are still reserved, and the technic is not of general acceptance [2, 5]. 
The Impedance Cardiography clinical potential, its relatively simple and economic 
implementation and the need to overcome its present limitations constitute the motivation to 
further study this seemingly valuable diagnostic technic. 
 
1.3. Goals 
This project aimed to develop a prototype system to monitor ICG signals, including 
the hardware for signal acquisition, the firmware controllers and the user interface to exhibit 
the relevant data while presenting basic operation options. The offline analysis of the data 
retrieved by the system can give information about physiological parameters. 
 
1.4. Thesis content 
This dissertation is divided into seven chapters. The first chapter comprises the 
framework and objectives of this project, describing its relevance, main goals and the thesis 
structure. The second chapter presents the theoretical background relevant to this project, 
addressing the main concepts behind electrical bioimpedance measurements, the outlines of 
the ICG signals, their acquisition and analysis for hemodynamic parameter extraction. The 
third chapter explains the development of a simple phantom produced in order to verify the 
ICG concept, relating the increase of blood in the chest vessels with the decay of thoracic 
impedance. The fourth chapter includes the description of the ICG acquisition system 
developed: the impedance unit, the commercial ECG unit included, the firmware operation 
and the user interface capabilities. In the fifth chapter the tests conducted at the hardware 
level to evaluate its general performance and the calibration procedure developed are 
presented. The sixth chapter reports the validation tests performed in order to verify the 
effectiveness of the developed system related to the ICG signal monitoring: the 
methodological guidelines for acquisition and analysis of ICG signals to obtain physiological 
information and the results of their application to acquisitions on volunteers are presented. In 
the seventh chapter the general conclusions from this work are summarized and future 
improvements are discussed.  
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This chapter begins with a physiological contextualization about the heart 
dynamics, followed by an introduction to the concept of Bioimpedance. The 
Electrocardiography (ECG) is presented in the terms relevant for the Impedance 
Cardiography (ICG) analysis. The general concept of the ICG technic is then explained, with 
a description of the electrical current limitations for human application, the method for 
measuring the thoracic impedance and the specific electrode dispositions that were 
applied in the studies during this project. The simplified impedance model of the human 
thorax and its relation to the Stroke Volume (SV) calculation is presented. Finally, the 
challenges of the ICG signal analysis in order assess hemodynamic descriptors are 
discussed. 
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2.1.  Circulatory system overview 
  
Figure 1) Human heart chambers and valves [6] and aorta detail [7]. 
 
The heart is a vital organ, launching the blood into the arteries and veins that delivers 
the oxygen to the cells and removes the carbon dioxide. It consists on a strong muscular wall, 
the myocardium, which alternated contraction – systole – and relaxation – diastole – causes 
blood pumping. The contraction is originated in the cardiac muscle cells that depolarize during 
the action state and repolarize during the resting state. The heart is divided in four chambers, 
two atria and two ventricles (figure 1), where the venous blood and arterial oxygenated blood 
flow separately from the atria to the right and left ventricles and from those into the 
pulmonary artery and aorta, to be driven across the pulmonary and systemic circulation, 
respectively. This unidirectional circulation of blood in the heart is assisted by the heart valves.  
 
 
Figure 2) Heart cycle [8]. 
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The left ventricle presents two functions: systolic ejection and diastolic filling (figure 
2). The systolic ejection follows an isovolumetric contraction period and occurs at elevated 
pressures. The high pressure is a requirement for efficient blood supply and fulfillment of the 
metabolic needs of the organism. Diastolic filling is preceded by an isovolumetric relaxation 
and occurs at low pressures, a pre-requisite for the correct blood oxygenation in the alveoli. 
The volumetric pressure causing the stretch of the ventricle wall at the end of diastole, before 
contraction begins, is the preload and the pressure developed on the left ventricle wall during 
ejection is the afterload. They describe the interaction between the heart, the venous system 
and the arterial system, respectively [9]. 
 
2.1.1. Systolic times 
Since the myocardial relaxation and contraction are orchestrated by intracellular 
ionic processes the timing of these events is related to the health of myocardial cells. The pre-
ejection period (PEP) includes the excitation-contraction coupling and the isovolumetric 
contraction time of the ventricle. The ejection time (LVET) occurs from the moment the 
ejection of the left ventricle begins, with the aortic valve opening, until the time the aortic 
valve closes. A healthy ventricle presents short PEP and large LVET [10]. 
 
2.1.2. Cardiac output 
Cardiac output (CO) is the volume of blood being pumped by the heart per minute, a 
product of the heart rate (HR) and stroke volume (SV). The SV of the ventricle is determined by 
its contractility, the preload and the afterload. The CO is an important parameter for the 
cardiac function evaluation, especially related to the ventricular performance, providing 
information about the body oxygen perfusion and giving insights about the hypertension 
origins. 
The most widespread method to measure CO is the invasive thermodilution method, 
considered the golden standard, which involves inserting a catheter into the circulatory 
system. The safety of such method is questionable, since catheterization is associated with 
increase of morbidity and mortality rate in critically ill patients [11]. The Impedance 
Cardiography (ICG) appears as a fitted alternative, offering a simple, safe and inexpensive 
method for non-invasive cardiac output monitoring and also providing assess to reliable 
systolic time intervals [3].  
Several studies tried to correlate invasive standard methods for assessment of SV 
and CO with ICG results presenting different degrees of success. The ICG technic shows high 
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correlations in subjects with stable circulatory system, but presents poor results in patients 
with failing circulatory system, valvular or other cardiovascular problem [12] and  under 
conditions of hypoxia, drugs and ventilator maneuvers [13, 14]. However, the determination of 
CO using the later ICG technology – commercial devices – seems to be less variable and shows 
better reproducibility on the same subject than the thermodilution, presenting equivalent 
results to the invasive method in patients after coronary artery bypass graft and showing 
improvements when compared to previous generation methods [2]. There is a general 
agreement that ICG requires more methodological investigation [5, 15], but is satisfactory for 
the determination of relative changes in cardiac output on normal subjects [13]. The 
contradictory appreciations of the technic over the years led to a reserved consideration of ICG 
data interpretations and the acceptance of the technique is still not generalized [2, 5]. 
 
2.2. Electrical properties of biological tissues 
Bioelectricity encompasses all the electrical phenomena in the living systems. In this 
context is relevant to distinguish between the phenomena that occur in response to externally 
applied (exogenic) electricity, such as the bioimpedance measurements, and the ones induced 
by internally generated (endogenic) electrical activity, as the heart beating, the nervous system 
activity and the muscle contraction. The ICG and ECG are examples of each one, respectively, 
with application in the study of human hemodynamics.  
The impedance of a biological tissue (Z) is a passive electrical property that quantifies 
its opposition to a current flow externally applied. This value is a complex number that can be 
calculated through the Ohm’s law (equation 1). The impedance value can be represented in 
one of two forms (equation 2): a complex exponential with amplitude |Z| and argument Ɵ, 
correspondent to the phase difference between voltage and current, or alternatively, as a 
combination of a resistance (R, real component of Z) and reactance (X, imaginary component 
of Z). 
 𝐼𝑚𝑝𝑒𝑑𝑎𝑛𝑐𝑒 =
𝑉𝑜𝑙𝑡𝑎𝑔𝑒
𝐶𝑢𝑟𝑟𝑒𝑛𝑡
 ( 1 ) 
 𝑍 = |𝑍|𝑒𝑗𝜃 = |𝑍|𝑐𝑜𝑠𝜃 + 𝑗|𝑍|𝑠𝑒𝑛𝜃 = 𝑅 + 𝑗𝑋 ( 2 ) 
The biological tissues in the human body are complex anisotropic conductors, where 
the electrical current flows due to the migration of ions. Their content in water and 
electrolytes determine the conductive characteristics: the resistive or reactive behavior. The 
lipidic cellular membrane presents a capacitive reactive behavior while the intracellular and 
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extracellular contents mainly present a resistive behavior. Accordingly, the current conduction 
will be different depending on the frequency: at low frequencies the current will pass around 
the cells, while at high frequencies the current will cross them (figure 3). This behavior is 
described by the Cole-Cole model that represents the tissue by an equivalent electrical circuit 
[16].  
 
 
Figure 3) Equivalent electrical circuit for biological tissues. Adapted from [17]. 
 
The electrical equivalent circuit represents the intracellular fluid as resistance (Ri) and 
the cellular membrane (Cm) as capacitance in parallel to the extracellular fluid resistance (Re). 
The Re, Ri and Cm values can be drawn from measuring the tissue’s impedance at various 
frequencies (f). The relation of this values to the overall impedance Z(f) is represented in a 
simplified way by the equation for the RRC circuit (equation 3).  
 
𝑍(𝑓) =
𝑅𝑒 × (𝑅𝑖 −
𝑗
2𝜋𝑓 × 𝐶𝑚
)
𝑅𝑒 + (𝑅𝑖 −
𝑗
2𝜋𝑓 × 𝐶𝑚
)
 ( 3 ) 
 
At low frequencies (𝑓 → 0) the cell membrane behaves as an insulator, therefore the 
capacitor acts as an open circuit and the current flows solely through the extracellular fluid. At 
high frequencies (𝑓 → ∞) the capacitor acts as a short circuit and the impedance results from 
the combination of the intra and extracellular fluid resistances [17].  
The ICG measurement process uses a single excitation frequency, to obtain the 
impedance value over a period of time. This way the Cole models are not of direct application 
in this context. 
 
2.3. Electrocardiogram 
The electrocardiogram (ECG) records the time-varying electric phenomena originated 
by the heart, through the measurement of the differential electrical potential between two 
Current flow Intracellular space (Ri) Extracelular space (Re) Cell membrane (Cm)
Low frequency current High frequency current Equivalent electrical circuit
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electrodes in contact with the body. The frequency spectrum of the ECG signal is between 0.05 
and 100 Hz, and its dynamic range is 1-10 mV [12, 18].  
 
Figure 4) ECG signal showing the characteristic points and waves in one cardiac cycle [19]. 
 
The characteristic shape of the ECG signal is related to the electro-mechanical events 
that occur during the cardiac cycle. The P wave represents the atrial depolarization. The 
ventricle depolarization forms the QRS complex, with the first downward deflection 
corresponding to the Q wave, the upward deflection the R wave and the final downward 
deflection the S wave. After the isoelectric segment, follows the ventricle repolarization 
corresponding to the T wave [19]. The RR interval, between two consecutive R waves, defines 
the heart rate (HR).  
The short-duration QRS complex is the most predominant feature on the normal ECG 
signal and presents special relevance for the ICG analysis. 
 
2.4. Impedance Cardiography 
Impedance Cardiogaphy (ICG) studies the volumetric variations of fluids in the human 
chest related to the cardiac activity, by measuring the changes in thoracic impedance during 
the heart cycle.  
The technic consists on applying a controlled alternating current, with constant 
amplitude and frequency, to the surface of the unknown chest impedance and measuring the 
established electrical potential, to estimate the impedance value using Ohm’s law [4].  
The thoracic impedance (Z(t)) consists of a relevant resistive component (15–45 Ω) 
and a negligible imaginary component, correspondent to an approximate 10° phase shift, 
which is not used for the purpose of cardiac evaluation [4] [20]. Each heart beat causes a 
pulsatile decrease (ΔZ) in the mean thoracic impedance (Z0) during systole, which implies a 
region in the chest where the blood volume is increasing [21]. The impedance values, from 
several measurements over time, are presented as an impedance waveform and the ICG signal 
is obtained as the first derivative of ΔZ. The typical ICG traces are accompanied by an 
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electrocardiographic (ECG) signal, recorded simultaneously to the impedance measurements, 
that serves as time reference. 
Hemodynamic parameters (systolic times and cardiac volumes, mostly) can be 
assessed based on the relative location of ICG and ECG characteristic points, in combination 
with the thoracic base impedance (Z0), thoracic dimensional descriptors and blood resistivity 
estimates, based on theoretical models. 
 
2.4.1. Current limits 
There is overall consensus in the use of sinusoidal currents with amplitude between 1 
and 5 mA and frequencies in the range 20–100 kHz for ICG applications. The lower current 
amplitude limit is the necessary to obtain sufficient SNR. Such current amplitude can lead to 
muscle excitation at frequencies lower than 20 kHz. At the frequency of 100 kHz the electrode-
skin impedance (section 2.5.2) is reduced when compared to low frequencies, which helps 
decreasing its disturbing impact in the cardiac signal. However, frequencies above 100 kHz 
introduce problems of stray capacitances [4].  
In the working frequency range the current amplitude must be defined in order to 
ensure that the potential induced on the heart muscle is substantially below the levels that 
might cause fibrillation (figure 5). 
 
 
Figure 5) Permissible AC-current (peak-to-peak values) through the human body in accordance to the Standard 
EN60601 for medical devises. Extracted from [17]. 
 
The application of DC currents to biological mediums is limited (table 1), since it 
causes the medium polarization due to electrochemical processes that take place in the 
aqueous conducting media, altering the ionic distribution. 
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Table 1) Effects of the DC current in the human body. Extracted from [22].  
Effect 
DC current (mA) 
Men Women 
Slight sensations in the hands 0.6 1 
Threshold  of perception 3.5 5.2 
Painless shock without loss of muscular control 6 9 
Painful shock without loss of muscular control 41 62 
Painful shock and fixation current threshold (let-go) 51 76 
Shock with intense pain, muscular contraction and breathing difficulties 60 90 
Possible cardiac fibrillation 500 500 
 
2.5.  Measurement methods 
The impedance measurement is commonly performed using one of two primary 
electrode configurations: the tetrapolar configuration (i.e. using four electrodes) or the bipolar 
configuration (i.e. using two electrodes). Most of the ICG procedures use at least four 
electrodes in order to overcome the influence of the skin electrode interface, which greatly 
affects the measurements in a bipolar configuration. 
In the bipolar configuration (figure 6) the current is injected through the same 
electrodes that sense the voltage. The voltage is measured not only across the unknown 
impedance but also across the cables, electrode contacts and skin impedances.  This additional 
impedance component is difficult to separate and introduces errors in the measurement. 
 
 
 
 
𝑍𝑚𝑒𝑎𝑠𝑢𝑟 =
𝑉𝑠𝑒𝑛𝑠𝑒
𝐼𝑔𝑒𝑛
 
= 2𝑍𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒−𝑠𝑘𝑖𝑛 + 𝑍𝑏𝑜𝑑𝑦  
Figure 6) Bipolar configuration, equivalent circuit and impedance mathematical description. The blocks represent 
complex impedances. 
 
In the tetrapolar-electrode configuration (figure 7), the four electrodes have different 
roles: the current is injected via two application electrodes (E1, E4) and the voltage is detected 
via the sensing electrodes (E2, E3). The influence of the electrode-skin interface impedance is 
minimized since the voltage sensing is made through high input impedance probes. Therefore, 
insignificant currents flow into the sensing leads and only the voltage differential across the 
load impedance is measured, providing a more reliable solution. The impedance can be 
approximated by the simple application of the Ohm’s law [4]. 
I(t)
V(t)E1 E2 E1
Zelectrode-skin,1
Zbody
Zelectrode-skin,2
I(t) Vsense(t)
Igen
Chapter 2: Theoretical Background 
13 
 
 
 
𝑍𝑚𝑒𝑎𝑠𝑢𝑟 =
𝑉(𝑡)
𝐼𝑔𝑒𝑛
 
 
𝑉(𝑡) = (𝐼𝑔𝑒𝑛 − 𝐼𝑑𝑒𝑣)𝑍𝑏𝑜𝑑𝑦 + 
+ 𝐼𝑑𝑒𝑣(2𝑍𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒−𝑠𝑘𝑖𝑛,2,3) 
 
 
𝑍𝑏𝑜𝑑𝑦 = lim
𝐼𝑑𝑒𝑣→0
(𝑍𝑚𝑒𝑎𝑠𝑢𝑟) 
Figure 7) Tetrapolar configuration, equivalent circuit and impedance mathematical description. 
 
2.5.1. Electrodes: type and topography 
The electrode that establishes the interface between the measurement device and 
the body, allows the electrical conversion from ionic conduction into electronic conduction, as 
the current passes from an electrolyte into a metallic conductor.  
One of the most popular methods for quantitative evaluations based on ICG, first 
reported by Patterson and Kubicek [23, 24, 25], was performed with a tetrapolar electrode 
system using band electrodes around the thorax extremities: two placed around the neck and 
two around the chest at the level of the xiphisternal joint and in the base of the ribcage. The 
outside bands inject current while the inner bands measure voltage. [26].  
 
Figure 8) Kubicek band electrode system. 
 
Although band electrodes offered lower impedance and presented bigger effective 
area, they were also difficult to handle and inappropriate for many clinical applications, for 
those reasons they have been substituted by spot electrodes. The common disposable spot 
electrodes provide precise transmission of surface bio-potentials developed across the human 
skin. They are constituted by aluminum or silver-silver chloride coated with hydrogel, which 
serves as adhesive and electrolytic medium, being physiological inert over short periods. They 
are commonly used in ECG and also ICG applications. 
I(t)
V(t)
E1 E2 E3 E4
Zelectrode-skin,1
Zbody
Zelectrode-skin,4
I(t) V(t)
Igen
Zelectrode-skin,2
Zelectrode-skin,3
Idev
Current 
application
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Some general rules concerning the electrode positioning on ICG can be pointed: to 
obtain reproducible measurements, the voltage electrodes must be placed with a distance of 
at least 3 cm from the application electrodes, avoiding the influence of high current densities 
around the last ones; the distance between the voltage electrodes must be kept constant 
between measurements since it affects substantially the value of Z0 but also ΔZ and (dZ/dt)max 
[26].  
Due to a lack of standardization, several tetra polar configurations using spot 
electrodes are described in the literature [27, 28, 26, 29, 30, 31]. Other configurations used in 
more complex systems apply a higher number of electrodes in order to optimize the 
measurement procedure [32, 33, 34]. Different configurations show different sensibilities to 
different signal sources, but in practice they produce similar SV estimations [34] and systolic 
times [35]. Two common tetrapolar configurations are further described since they have 
particular interest for this project. These configurations present easy reproduction based on 
body markers.  
 
2.5.1.1. Anteroposterior configuration 
The configuration proposed by Qu et al [28] places the electrodes in the sagittal 
plane: the current application electrodes are located posteriorly, one above the C4 vertebra 
and a second one between the thoracic vertebras T8-T9; the voltage sensing electrodes are 
located frontally one at the base of the neck, above the jugular notch, and a second one over 
the sternum leveling with fourth rib. 
 
Figure 9) Tetrapolar electrode configuration from Qu et al. 
 
2.5.1.2. Posterolateral configuration 
The tetrapolar configuration suggested by Penney et al. [27] places two electrodes in 
the posterior surface of the neck separated by 6 cm and centered on the C7 prominence. The 
Voltage 
sensing
Current 
application
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remaining electrodes are placed on the left side of the thorax: one on the mid-clavicular line, 
at the end of the ninth intercostal space and the second in the mid-axillary line at the end of 
the tenth intercostal space. The current passes through the electrodes on the right side of the 
neck and on the left mid-clavicular line, while the remaining electrodes sense the voltage. 
 
 
Figure 10) Tetrapolar electrode configuration from Penney et. al. 
 
2.5.1.3. Electrode polarity  
The electrode polarity is usually not specified, which might reflect its irrelevance. 
Although some commercial devices specify the electrode polarity, their suggestions do not 
agree: the Biopac system’s web page suggests the position of the two positive (high current 
and voltage) electrodes above the two negative ones (low current and voltage) [31] and the 
user’s manual [36] from the Vrije Universiteit Ambulatory Monitoring System [37] specifies the 
location of the two negative electrodes above the heart level and the positive ones below.  
 
2.5.2. Electrode-Skin interface 
Not only the contact electrode-skin presents a resistance to the current flow, as also 
the electrode electrical behavior can affect the measurements by introducing a DC bias, in 
result of changes in the electrode potential [38]. 
The standard electrode can be described by a simplified equivalent circuit (figure 11) 
with passive components, not accounting the DC drift. The model includes three serial 
impedances: the skin (Zskin), the contact (Zcontact) and the electrode (Zelectrode). The value of the 
skin impedance amplitude approaches 220 Ω at 100 kHz, the contact impedance, 
corresponding to the resistance of the hydrogel, is near 88 Ω and the electrode impedance 
amplitude is around 3 Ω [39]. 
 
Side
Current 
application
Voltage 
sensing
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Figure 11) Electrode-skin interface circuit for the typical spot electrode. Adapted from [17]. 
 
2.6.  Source of the ICG signal 
The blood is characterized by its high conductivity, presenting a resistivity two times 
lower than the muscle and many times higher than the less resistive tissues. Relative to static 
conditions, the flowing blood presents a decrease in resistivity of at most 10% [40].  This data 
supports the idea that in ICG the change of the impedance signal is mostly caused by blood 
volume translocations, while other tissues either maintain the volume or present distinctively 
higher resistivity. In the particular case of the myocardium the resistivity is five times higher, 
leading to the electrical isolation of the blood inside it [4].  
Furthermore, after several analysis, the cardiac hemodynamics, i.e. changes in blood 
volume and velocity, were considered the main cause of impedance variations [41]. The 
varying speed of ejection specially affects the systolic part of ΔZ, while the diastolic part of the 
impedance signal exhibits the effect of volume alterations [13]. Other conclusions were drawn 
in respect to the ICG signal [42]: it is a complex signal resulting of multiple sources 
contribution; its components are not synchronized and their proportions not well defined; it is 
dependent on changes in the aorta diameter, neck arteries and pulmonary vessels and also on 
the change of blood resistivity related to cell reorientation in large vessels; it seems to be 
independent of the heart volume and its blood content, thanks to the isolating properties of 
the myocardium; for typical electrode positions it is not affected by the extension of the 
pulmonary artery. These illations, while interesting, do not clarify the origin of the ICG signal, 
which is still an object of study, pointing out the weakest feature of the technic [13]. At this 
point, there is still controversy between most authors [43] and more investigation is still 
needed in this area. 
Currently, the changes in thoracic impedance related to the cardiac activity are 
accepted as caused primarily by ejection of blood from the left ventricle into the aorta, having 
a close relation to the SV [4]. As the current flows through the path of least resistance, mostly 
Rcontact
Rskin Relectrode
CelectrodeCskin
Zskin ZelectrodeZcontact
Electrode-skin interface
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the aorta that carries the largest volume of blood in the thorax, the cyclic expansion causes a 
pulsatile change in the base impedance [15]. 
 
2.6.1. Simplified model of the human thorax 
In a very simplified model, the chest region impedance is represented as a cylinder 
divided in two parts: the tissue and the blood (figure 12). The impedances of the partial 
cylindrical volumes are electrically connected in parallel. If the subject does not breathe the 
only fluid variation is related to the amount and distribution of blood during the heart cycle. 
The blood volume changes would be represented as variations in the crossectional area, i.e. 
the ejection of blood from the heart would be represented as an increase in diameter. 
 
 
Figure 12) Parallel conductor model for the human thorax impedance, with uniform blood and tissue 
compartments with crossectional areas Ab and Al, respectively and constant length L. Extracted from [13]. 
 
Based on the parallel model assumptions, the general expression to describe the 
increment of blood (ΔV) as a function of the correspondent decrement of the electrical 
impedance (ΔZ) in a cylindrical region of the body was derived by Nyboer (equation 4) [13]. 
Where ρ is the blood resistivity, L is the length of the cylindrical model and Z0 is the mean 
impedance of the model. 
 
𝛥𝑉 = −
𝜌𝐿2
𝑍0
2 𝛥𝑍 ( 4 ) 
The ΔV and ΔZ vary almost periodically with the heart pulsation, ΔV=ΔV(t) and ΔZ=ΔZ(t), while 
the mean value Z0 changes slowly, typically in accordance to the pulmonary function, Z0=Z0(t). 
Thus Nyober proposed the partition of the measured impedance into two additive 
components with distinct magnitude and spectra (equation 5) [44]. 
 𝑍(𝑡) = 𝑍0(𝑡) + 𝛥𝑍(𝑡) ( 5 ) 
The validity of the parallel cylinder model was questioned after inaccurate results, 
and subsequently more complex models were developed (multi-cylinders or models 
representing the main blood vessels). Although, when compared with practical studies the 
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results from such models would still not agree in relation to the origin of the impedance signal 
[13]. 
 
2.6.2. Method for stroke volume calculation 
Kubicek proposed the modification of Nyober’s formula (equation 4) in order to 
obtain the SV. Provided that the maximum peak of the impedance derivative ((dZ/dt)max) is a 
mean blood acceleration analog during systole, it permits its integration during the ejection 
time, in order to obtain the impedance variation (ΔZ) analog (equation 6) [45, 13]. It should be 
noticed that the peak value of the ΔZ derivative is a negative value, sometimes referred as 
(dZ/dt)min, that is conventionally taken in the upward direction (in module) and referred as 
(dZ/dt)max, since the signals on the Nyober’s expression cancel out. 
 
∆𝑍 = 𝐿𝑉𝐸𝑇 × (
𝑑𝑍
𝑑𝑡
) 𝑚𝑎𝑥 ( 6 ) 
This way the volume variation of blood during systole can be identified with the SV as 
given by equation 7, where SV is the stroke volume (ml), ρ is the blood resistivity (Ω.cm), L is 
the distance between the inner sensing electrodes (cm), Z0 is the base impedance (Ω), 
(dZ/dt)max is the largest peak occurring during systole on the impedance signal first derivative 
(Ω/s) and LVET is the left ventricular ejection time (s) [12]. 
 
𝑆𝑉 = 𝜌
𝐿2
𝑍02
𝐿𝑉𝐸𝑇 × (
𝑑𝑍
𝑑𝑡
) 𝑚𝑎𝑥 
( 7 ) 
 
This method is widely used to estimate SV from impedance recordings, but being 
based in the two-compartment cylindrical model it presents a big abstraction and the change 
in blood resistivity with velocity is completely neglected [13]. 
Other methods for stroke volume calculation based on more accurate geometric 
models and considering other particular descriptors of the subject are available [45]. Thus such 
models, as well as the presented one, are able to provide a reliable SV estimation [4]. 
 
2.6.2.1. Blood resistivity value 
The blood resistivity (ρ) is one of the parameters in Kubicek’s formula which makes it 
accurate assessment necessary.  Two approaches to its determination are referred: ρ as a 
constant with a value between 130 and 150 Ω.cm or ρ as a function of the hematocrit – 
percentage of red blood cells on the total blood volume. Even though significant variations of 
the hematocrit are reported in diseased individuals [46], the use of constant values to obtain 
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the SV using Kubicek’s formula proved to have strong correlation with direct methods of 
measurement [4]. In this basis seems to be good practice to rely on a constant value when 
performing ICG in healthy subjects, in an outpatient setting. 
 
2.7. Impedance Cardiography signal analysis 
The term ‘impedance’ is usually applied indiscriminately when referring to the ICG 
evaluations. Although, there are suggestions that both the magnitude [47, 48, 45] and the 
resistive part [42, 20, 49] are applied in different studies. This question is irrelevant when 
neglecting the effect of the thoracic reactance, which is probably in the base of the lack of 
distinction.  
The base thoracic impedance (Z0) value varies between subjects, frequency of the AC 
current and with the electrode configuration. For SV calculations the most important 
component of the thoracic impedance is related to the changes (ΔZ) in the main impedance 
[45]. The ΔZ due to blood circulation is influenced by respiration and motion artifacts, that 
present relatively large amplitude and can cause relevant baseline wander [50]. Such artifact is 
fundamentally caused by changes in the chest dimensions during the breathing cycle (figure 
13). 
The impedance cardiography (dZ/dt) spectrum extends from DC to 50 Hz [51]. The 
respiratory related component is in the range of 0.04-2 Hz, while the motion artifact band is 
between 0.1-10 Hz [50]. Thus, the ICG and the artifact spectra overlap. This way, the baseline 
for further calculations has to be determined separately for each heart cycle or otherwise the 
low frequency modulation has to be removed from the signal. The elimination of such effect 
can be performed by one of the following methods [4]. 
 Temporary elimination of breathing: despite breathing modulation removal, it affects 
the cardiac volumes and is not appropriate to perform some physiological tests such as 
exercise or extended monitoring; 
 Application of ensemble averaging methods: several sets of data are obtained and 
averaged together to reduce random fluctuations of the signal and provide the mean curve 
during a certain period of time. The information concerning beat-to-beat variations is lost and 
some features are commonly blurred. The time frames for averaging are determined in respect 
to an intrinsic reference point or to another reference signal. The R wave from the 
simultaneously acquired ECG is typically used to synchronize the ICG ensemble average on a 
beat-by-beat basis. 
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 Digital filtering: this probably presents the most flexible solution. Although, the use of 
a narrow filters centered on the heart rate seems to introduce nonlinear phase distortion and 
attenuates the high frequency components. Plus, adaptive filtering presents the disadvantages 
of not correctly cancel the respiratory and motion artifact, since they overlap the spectrum of 
cardiac signal [50].  Other straightforward filtering technics are still in investigation. 
 
 
Figure 13) Influence of breathing on the thoracic impedance [52]. 
 
Despite being considered an interference in the ICG signal analysis, several authors 
have studied the respiratory impedance signals derived from ICG in order to extract 
information related to the respiratory function [53, 54, 20]. 
 
2.7.1. Characteristic points and periods 
The derivative of the impedance variation, the so called ICG signal, is used to assess 
the hemodynamic parameters (figure 14). Despite the attempts to draw conclusions based on 
qualitative differences in the morphology of the ICG signal - mostly related to diagnosis of 
valve malfunction – their immature state confines the ICG analysis mainly to quantitative 
estimation of cardiac parameters [4]. 
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Figure 14) ICG typical waves (ΔZ, dZ/dt presented in the upward direction) and ECG reference signal. Adapted 
from [13]. 
 
Several notches of the ICG curve were associated with different mechanical events 
that occur during the cardiac cycle [55]. Those points are identified by the letters A, B, C, X, Y, 
O, Z, similarly to the ECG, and their description is presented on table 2. 
 
Table 2) Characteristic points on the ICG signal [4]. 
Characteristic point Description 
A (atrial wave) Associated with the atrial contraction; its amplitude is related to the 
ejection fraction of the left atrium. 
B Associated with the aortic valve opening, it denotes the beginning of 
the (left ventricle) ejection time. It appears on the ascending section of 
the ICG signal before (dz/dt)max, at the baseline level. Its identification 
can be problematic since the characteristic upstroke used as its marker 
may be indistinct. The correct localization of this point in the ICG curve 
is crucial for accurate calculation of systolic time intervals, SV and CO. 
C (also called E) Reflects the maximum speed of change in the impedance and is 
associated with the maximum ejection velocity. The (dz/dt)max is the 
maximum amplitude of the signal, measured from the baseline to the C 
point location. 
X Corresponds to the aortic valve closure (the second heart sound) and 
appears as the lowest value in the negative portion of the ICG signal 
after C. 
Y Corresponds to the pulmonary valve closure. 
O Wave associated with changes in volume during the diastole and with 
the opening sound of the mitral valve. 
Z Associated with a third heart sound, it corresponds to a downward 
deflection after the O wave. 
 
Time [s]
ECG
ICG=dZ/dt
ΔZ
(dZ/dt)max
Q
R
A B
C
XYOZ
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The ICG notches are best noticeable in signals collected from healthy subjects while 
lying down either in the supine or prone position [49].  
The temporal relations between some characteristic points in the ICG signal present 
physiological and clinical relevance.  From the characteristic periods indicated on table 3, the 
most frequently studied are PEP and LVET which present direct relation with the heart systole. 
 
Table 3) Characteristic periods in ICG [4]. 
Characteristic period Description 
Q-B 
 
Time between the onset of the heart chambers contraction (Q point 
in ECG) and the aortic valve opening. It is denominated the pre-
ejection period – PEP - and is commonly used as an index of 
myocardial contractility and sympathetic control of the heart. 
Q-C Time between Q point (ECG) and the ICG curve maximum. It is 
applied to calculate the Heather index for cardiac contractility. 
B-X Time between the opening and closure of the aortic valve, 
corresponding to the left ventricular ejection time – LVET. 
 
2.7.2. Hemodynamic parameters 
The most relevant hemodynamic parameters that can be extracted from the ICG 
signal analysis (table 4), apart from the systolic intervals, are the SV and the CO.  
 
Table 4) Hemodynamic parameters [4]. 
Hemodynamic parameter Description 
Stroke Volume (SV) Volume of blood pumped by the left ventricle during one 
contraction cycle, is expressed in milliliters per beat [ml/beat]. 
Cardiac Output (CO) Volume of blood ejected by the heart into the systemic circulation 
during 1 min, is expressed in [L/min]. It is defined as the product 
of SV and the heart rate (HR), or by the sum of all SV values 
occurring during the period of 1 min. 
Systolic Time Ratio (STR) Ratio PEP/LVET, is considered as an index of cardiac contractility. 
Total Fluid Content (TFC) The inverse value of the base impedance (Z0), is expressed in 
[1/kΩ]. It is an indicator of the fluid content in the thoracic cavity. 
Heather index 
 
Cardiac contractility index defined as the ratio of (dz/dt)max to the 
Q-C period, expressed in [Ω/s2]. It represents the rate of 
impedance change from the beginning of the cardiac contraction 
to the peak of the mechanical action. 
 
From the referred hemodynamic parameters, several hemodynamic indices [4] can 
be derived using the characteristic points and periods taken from the ICG and ECG curves, 
blood pressure and/or other body characterization parameters. 
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This chapter presents the methodology involved in the development of a simple 
bench system in order to replicate the decrease in thoracic impedance with an increased 
blood volume in the vessels near the heart.  
The results from the impedance measurements performed on a static phantom 
composed of several agar-agar volumes embedded on a relatively low conductive aqueous 
solution are presented and discussed. 
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As follows from the ICG concept, the blood ejection during the cardiac systole causes the 
surrounding structures to swell due to blood inflow [56] and accordingly, a decrease of 
thoracic impedance is registered (section 2.6). To verify that an increase of a conductive 
volume within less conductive surroundings causes a depletion of the impedance measured 
across the whole system, a static phantom was developed. 
The resistivity of the thoracic tissues, without considering heart and lungs, is 
approximately three times higher than the resistivity of blood [57]. This physiological ratio was 
the primary point considered when choosing the phantom materials and adjusting their 
conductive properties to electrically mimic the blood and thoracic tissue. 
 
3.1. Materials and methods 
To perform impedance measurements a portable Electrical Impedance Spectroscopy 
(EIS) system described by Borges et al. [58], was employed. The system works in a bipolar 
configuration with needle electrodes. The present formulation of such system allows the 
measurement of impedances down to 100 Ω without incurring in error, that limitation had to 
be accounted in the phantom development. All the impedance measurements were the result 
of applying an excitatory AC voltage to the sample in study. In this procedure three excitatory 
frequencies in the range of the ICG specifications were studied - 50 kHz, 70 kHz and 100 kHz. 
During the described procedures the materials were weighted using a balance with 
scale 0.4-500 g and precision 0.1 g. For liquid volumes greater than 150 mL a graduated 
recipient with scale 100 to 1000 mL and precision 100 mL was used. For more precise 
measurements or smaller liquid volumes was used either a graduated syringe with scale from 
2-100 mL and precision 2 mL or one with scale 1-60 mL and precision 1 mL. 
 
3.1.1.  Electing the materials 
The agar-agar alga is commonly used to develop nutritive media for microorganism 
cultures. Thanks to its consistency - similar to gelatin - it has also been employed on the 
conception of phantoms simulating solid bodily tissues [59, 60, 61]. A preliminary test on 20 
mL solidified agar-agar samples prepared with distilled water (1.15% (m/m)) resulted on a 
resistance close to 4.5 kΩ (and reactance near -133Ω) at an excitation frequency of 100 kHz. 
Even though the average value of thoracic impedance could not be reached attending to the 
limitations of the EIS system, the agar-agar sample resistance was worked on to present a 
better approach to such value. The reactance value was only taken for control.   
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The electrical conductivity of water is directly dependent on the concentration of 
salts dissolved on it. Distilled water has low ionic concentration, hence presenting high 
resistivity. The smaller the ions dissolved, the faster they travel across the solution, increasing 
the conductivity. Strong acids and bases, with high degree of ionization in water, cause a more 
drastic increase in the conductivity than weak acids or bases, which partially ionize, or salts, 
that provide larger ions. 
In order to decrease the agar-agar resistivity, in a controlled way, two easily 
affordable resources were explored: sodium chloride (NaCl) and citric acid (C6H8O7). The NaCl, 
known as the ordinary table salt, dissociates into sodium and chloride ions when dissolved in 
water. Citric acid is a weak organic acid found in lemon or lime juice in more significant 
quantities than in other citrines. These two substances in low concentrations allow an easy 
manipulation of the conductive properties of a solution. 
After a trial and error process, the results that better approached the required 
impedance for the low resistive medium were obtained by adding natural lemon juice to the 
agar-agar preparation and then correcting the results with NaCl. Alongside, acceptable results 
were obtained with an aqueous solution of lemon juice in distilled water, as the less 
conductive medium.    
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3.1.2.  Phantom models and Practical limitations 
Table 5) Idealized phantom models 
Geometry 1: cylindrical solid 
container. 
Geometry 2: rectangular shape. 
Geometry 3: cylindrical central 
mass embedded on liquid 
solution. 
 
 
 
 
 
 
  
 
e – electrodes; I – internal content (blood-like); E – external content (resistive tissue-like). 
Advantages 
 The geometry agrees with 
the simplified models for the 
human thorax; 
 Enables the use of ICG 
electrodes. 
 The several rectangular pieces 
can be easily shaped; 
  Enables the use of ICG 
electrodes. 
 Since the electrodes are fixed 
to the container sides, the 
distance between electrodes 
can be easily maintained 
between measurements. 
Disadvantages 
 The variation of the internal 
content is not possible using 
the same phantom: several 
cylinders with different 
central diameters are 
needed; 
 To avoid leakage the central 
pool cannot trespass the 
cylinder and the pool depth 
might vary between different 
phantoms; 
 The internal content 
consistence and shape have 
to be optimal to permit 
correct juxtaposition;  
 Removing the agar from the 
cylindrical mold was proven 
to be difficult without 
damaging it.  
 The central mass has to 
present a consistence that 
permits the correct 
juxtaposition of surfaces; 
 Several phantoms with 
different central volumes are 
needed; 
 The difficult maintenance of 
the distance between 
electrodes. 
 Needs several central masses 
with different volumes; 
 The ICG spot electrodes 
cannot be used; 
 The external content has to 
be liquid while the central 
mass is solid which does not 
agree with the physiologic 
reality; 
 The electrode disposition is 
not in accordance to the ICG 
reality that disposes the 
electrodes along the vertical 
conductive axis, 
perpendicularly to the tissue 
swelling. 
 
The three configurations described in table 6 were tested in miniature set-ups. The 
first and second geometries shown similar practical problems: the distance between 
electrodes was difficult to maintain since there was no direct point of reference between 
phantoms; and the interface between solid samples presented a highly resistive barrier to the 
current even when the surfaces were pressed together. The third geometry shown to be the 
simplest and most reliable, even though it did not reproduced the theoretical models and 
could not be used to perform tests with the real ICG spot electrodes that need to be attached 
on a solid surface. 
e 
e 
e e 
e e 
I 
E I E E 
E I 
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3.1.3. Final formulation 
In its final formulation, following the third geometry in table 5, the phantom was 
composed by four agar-agar masses with different volumes surrounded by an aqueous 
solution composed of 9.1% (v/v) natural lemon juice on distilled water (resistivity >200 kΩ.cm). 
The agar-agar was prepared from an aqueous solution of 0.2% (m/m) NaCl and 1.4% (m/m) of 
agar-agar for food applications on distilled water. This solution was heated with a microwave 
oven (Power=800 W) inside a Pyrex container for a total of 6.5 minutes. To prevent the 
solution from boiling - which would render its density uneven - the heating time was divided 
into successive intervals of 120, 60, 60, 45, 45, 30 and 30 seconds and at the end of each 
heating period the solution was stirred. Natural lemon juice was then added to the agar while 
it was still liquid (temperature>50 °C), to make up for 4.8% (v/v) of the initial volume of 
solution. 
A control sample of 20 mL was collected and the remaining agar-agar was then 
disposed on a plane PP (polypropylene) container (⌀ 15cm) to cool down at ambient 
temperature for 2 hours. Then the container was covered and transferred to the fridge, where 
it stood for around 6 hours. The measurements were performed with agar-agar at ambience 
temperature, after it was out of the fridge for a few minutes. To avoid problems with the 
adherence to the walls of the container, the agar-agar was chopped of the container with 
circular cutting molds after its solidification (figure 15). 
The aqueous solution was prepared in slots of 330 mL right before the 
measurements took place by stirring together the distilled water and the lemon juice. After 
that a 20 mL sample was collected for evaluation. 
To prove the repeatability of the experience two phantoms were separately realized 
following the procedure described above. The final results presented are averaged values of 
the evaluations performed in each phantom. For every sample tested the impedance was 
measured two times at each frequency (f) of interest – 50 kHz, 70 kHz and 100 kHz – and then 
averaged with respect to each frequency. 
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Figure 15) Agar-agar cylindrical masses (1)/(3) and molds (2)  used to cut them (⌀=6.63 cm, 5.59 cm, 5 cm and 4.02 
cm, from left to right). 
 
The 20 mL samples of aqueous solution and agar-agar, collected inside PP containers 
(Ø = 4.6 cm), were used to the indirect evaluation of their relative resistivity, by measuring 
their impedance using similar electrode configurations (figure 16). The resistivity approximated 
evaluation is made according to equation 8, considering that the real part of the impedance is 
proportional to the resistivity. 
 
𝑅 =
𝜌𝐿
𝐴
 ( 8 ) 
 
Figure 16) Set up for measuring the impedance (left) of 20 ml samples of solution and agar-agar inside PP 
containers (right): (1) holder claw, (2) EIS system grip and (3) needle electrodes. (Mean de=3.71 cm and ~0.5 cm 
from the point of contact with the grip to the electrode top.) 
 
❶ ❷ 
❸ 
Solid sample of agar-agar 
with NaCl and lemon 
juice 
Aqueous solution of 9.1% 
v/v lemon juice ❶ 
❷ 
❸ de 
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The agar-agar sample impedance was also measured outside the container, on a 
glass surface (Pyrex), to test the container’s effect.  
The electrode configuration was kept as constant as possible by using holder claws to 
help maintaining the distance between the electrodes and their vertical insertion into the 
samples. It was verified that little variations in the distance between the electrodes introduced 
notorious variations in the impedance reading. The length of the needle inside the sample also 
affected the results, although in a less pronounced way. The vertical variation of the point 
where the needle would contact the grip did not show appreciable effects on the result. The 
absolute error associated with the variation of the electrode disposition from measurement to 
measurement was estimated in 0.1 cm, accounting only 2.7% of the distances between them, 
in the range 3.69-3.75 cm. 
The results (figure 17) from comparing the measurements on the agar-agar 20 mL 
samples inside and outside the PP containers, showed that the container induced a maximum 
increase of 13% in the resistance, relatively to the value measured on the glass surface. 
Obviously, such effect was not evaluated on the liquid samples.  Since the purpose of using 20 
mL samples was to obtain normalized values of impedance, assuring that the resistivity of the 
solid sample was lower than the liquid one (figure 18), the error introduced by the container 
was ignored, since all values would be inflated in the same direction, which would not affect 
the ratio between the impedance of internal and external phantom components. 
 
Agar-Agar impedance evaluation on 20 mL samples 
  
 
Figure 17) Agar-Agar impedance evaluation on 20 mL samples: Average values from two phantoms with similar 
formulations. The error bars reflect the standard error of the mean. 
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Aqueous solution impedance evaluation on 20 mL samples 
  
Figure 18) Aqueous solution impedance evaluation on 20 mL samples: Average values based on samples taken 
from two phantoms with similar formulations. The error bars reflect the standard error of the mean. 
 
After the initial evaluation confirmed the expected relative resistance values, and 
before being included into the aqueous solution, the agar-agar volume (V) was estimated 
based on the mold diameter (D) and the measurement of their average height (h) using a 
caliper (table 6), according to equation 9.  The errors in the direct measurements were 
estimated based on the visual evaluation of the maximum uncertainty for each situation, since 
the error associated to the caliper measurement did not reflect the real procedure limitations.  
 𝑉𝑜𝑙𝑢𝑚𝑒 (𝑉)  =
𝜋 𝐷2
4
ℎ ( 9 ) 
The uncertainty on the volumetric values (𝛿𝑉, equation 10) of the agar- agar on table 
6 was obtained by error propagation, according to the next expression, where 𝛿𝐷, and 𝛿ℎ are 
the uncertainties of the diameter and height of each sample, respectively. 
   𝑉𝑜𝑙𝑢𝑚𝑒 𝑢𝑛𝑐𝑒𝑟𝑡𝑎𝑖𝑛𝑡𝑦 (𝛿𝑉)  =
𝜋 𝐷
2
√ℎ2𝛿𝐷2 +
𝐷2𝛿ℎ2
4
 ( 10 ) 
The aqueous solution volume was measured using a graduated syringe, and the 
uncertainty of the measurement was considered as the smaller scale division of the syringe to 
account for adherence processes. 
 
Table 6) Phantoms volumetric description: the volumes of aqueous solution and agar-agar are indicated. 
Sample 
Mold 
diameter, D 
(cm) 
Phantom 1 Phantom 2 
Height, h 
(cm) 
Volume, V  
(ml) 
Height, h 
 (cm) 
Volume, V 
(ml) 
Aqueous 
solution 
- - 250 ± 2 - 250 ± 2 
Agar v1 4.02 ± 0.10 
1.23 ± 
0.50 
15.61 ± 6.39 
1.20 ± 
0.50 
15.23 ± 6.39 
Agar v2  5.00 ± 0.10 24.15 ± 9.86 23.56 ± 9.86 
Agar v3  5.59 ± 0.10 30.19 ± 12.32 29.45 ± 12.32 
Agar v4 6.63 ± 0.10 42.46 ± 17.31 41.43 ± 17.31 
1578,5
1581,51583,2
1400
1450
1500
1550
1600
1650
1700
40000 50000 60000 70000 80000 90000 100000 110000
R
es
is
ta
n
ce
 (
Ω
)
Frequency (Hz)
-8,5
-11,9
-12,6
-18
-16
-14
-12
-10
-8
-6
-4
40000 50000 60000 70000 80000 90000 100000 110000
R
ea
ct
an
ce
 (
Ω
)
Frequency (Hz)
Chapter 3: Phantom Setup 
31 
 
After securing the EIS system electrodes on two supports with claws above a round 
PP container (Ø = 17.5 cm) (figure 19), the aqueous solution was added to the container and its 
impedance was measured. The aqueous solution volume was enough to vertically bath the 
agar-agar masses, without going over them.  
 
 
Figure 19) EIS system and experimental set-up: (1) laptop running a Matlab® based user interface for data 
processing;  (2) PicoScope® acquisition interface and signal conditioning unit of the EIS system with electrode 
grips to grab the needle electrodes in contact with the samples; (3) Phantom. 
 
To make sure the electrodes would not move in a significant way from measurement 
to measurement, two squared marks were placed at the bottom of the container, on the 
outside. The central points of the squared marks were 14.5 cm apart and the maximum 
deviation of the distance between electrodes from that value was confined to 0.7 cm – the 
width of each mark – between measurements. A third mark was placed in the center of the 
container to assure the central placement of the agar-agar masses. 
 
 
Figure 20) Detail of the phantom setup: central mass of agar surrounded by the aqueous solution. The needle 
electrodes are held beneath the marks location on the bottom of the container. 
❶ 
❷ 
❸ 
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Due to practical constringent - to prevent the movement of the whole system -, the 
aqueous solution volume was not completely substituted between measurements within the 
same phantom, with different agar-agar masses, but only adjusted. 
One agar-agar mass at a time was included in the solution with the assistance of a 
spatula and for each of them an equivalent volume of solution was removed. The solution 
volume was reposed to 250 mL at the end of each measure after one agar mass was removed 
and before another was included. There were performed auxiliary measurements in the 
phantom with each of the agar-agar masses within the complete 250 mL (before the volume 
adjustment) to make sure the same impedance evolution would take place.  
To assure that the variation of resistivity or volume along the procedure would not 
affect the results, the solution impedance was measured again after taking the last agar 
sample off and reposing the 250 mL of solution. 
To avoid damaging the agar-agar masses their impedance was only evaluated after 
being bathed in the solution. Such evaluation was performed by disposing the agar samples 
above a glass surface and inserting the needle electrodes vertically into the sample, at 
approximately 0.25 cm from their periphery – in a configuration similar to that shown in figure 
16.  
 
3.2. Results and discussion 
The resistance ratio between the external and internal medium had an average value 
of 3.38, considering data from the impedance evaluation on the 20 mL (figure 17 and figure 
18), which is a close approximation to the physiological ratio. 
The final evaluation of the aqueous solution showed a decrease of the resistance 
values in both phantoms (table 7).  For the first phantom, the resistance variation was not 
significant since it was inferior to the variation induced by the smaller agar-agar volume. For 
the second phantom, the variation of resistance was more relevant, presenting a variation 
almost as high as the one measured with the larger agar-agar mass. The resistance decrease 
can be justified based on an erroneous adjustment of the final volume or in the resistivity 
alteration due to contamination of the sample. This does not invalidate the results since the 
overall resistance variation due to the agar-agar masses was higher. 
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Table 7) Impedance properties of the aqueous solution alone on the phantom container, at the beginning and at 
the end of the measurements. The uncertainties reflect the standard error of the mean. 
Aqueous solution 
f 
(kHz) 
Phantom 1 Phantom 2 
R (Ω) X (Ω) R (Ω) X (Ω) 
Initial phantom content 
100 2063.3 ± 0.1 -20.9 ± 0.5 2044.3 ± 0.2 2.2 ± 0.3 
70 2075.5 ±0.5 -29.7 ± 0.2 2049.3 ± 0.4 -7.1 ± 0.2 
50 2085.9 ± 1.3 -34.1 ± 0.3 2052.8 ± 0.4 -11.4 ± 0.1 
Final phantom content 
100 2012.5 ± 1.6 -18.2 ± 0.5 1855.5 ± 0.4 0.9 ± 0.3 
70 2022.0 ± 0.3 -25.8 ± 0.1 1858.3 ± 0.1 -5.9 ± 0.2 
50 2028.8 ± 0.8 -28.9 ± 0.8 1860.4 ± 0.4 -11.0 ± 0.3 
Average Δ - 53.8 ± 1.5 3.9 ± 0.6 190.7 ± 0.8 0.94 ± 0.2 
 
Since all agar-agar solid components included in the phantoms where made from the 
same material it was expected that the greater their volume (and consequent diameter) the 
higher the resistance.  
 
Phantom 1 – Agar-agar impedance 
  
Average standard error of the mean = 0.05 Ω Average standard error of the mean = 0.06 Ω 
 
Figure 21) Impedance evaluation on individual agar-agar volumes from phantom 1: Resistance (left) and 
reactance (right) as a function of the excitatory frequency. The distances between the electrodes  during the 
measurements where: 3.54 cm, 4.4 cm, 4.95 cm, 6.21 cm for v1, v2, v3 and v4, respectively. 
 
The impedance evaluation of the agar-agar volumes showed an abnormal high 
resistance value on the sample V3 from phantom 1, with a value that surpassed the resistance 
of V4 (figure 21). This was probably due to contamination of the sample in the process of 
inclusion onto the phantom. All the other values behave as expected. 
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Phantom 2 – Agar-agar impedance 
  
Average standard error of the mean = 0.09 Ω Average standard error of the mean = 0.06 Ω 
 
Figure 22) Impedance evaluation on individual agar-agar volumes from phantom 2: Resistance (left) and 
reactance (right) as a function of the excitatory frequency. The distances between the electrodes  during the 
measurements where: 3.5 cm, 4.41 cm, 5.01 cm, 6.15 cm for v1, v2, v3 and v4, respectively. 
 
In the second phantom, the resistance values from the agar-agar samples increased 
with the samples volume (figure 22), as expected. In both phantoms, the reactance values do 
not show a clear relation with the sample volume, presenting similar values at the same 
excitatory frequency. 
The following data corresponds to the average of the two phantoms (at the same 
frequency, volume and measurement setup conditions) for ease of visualization. The agar-agar 
volumes were also averaged. The error values presented are a good reflection of the 
concordance between phantoms. In figures 23 and 24, the value at V=0 mL corresponds to the 
initial measurements on the aqueous solution, without any agar-agar mass. 
 
Resistance vs. Conductive volume  
(With corrected liquid content) (With the total liquid content of 250 mL) 
  
Average standard error of the mean = 11.5 Ω Average standard error of the mean = 10.2 Ω 
 
Figure 23) Phantom resistance as a function of the conductive volume for measurements after adjustment of the 
liquid volume (left) and with the total liquid content of approximate 250 mL (right). Each label indicates the 
resistance value at 70 kHz. 
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The measurements performed on the samples surrounded by 250 ml of aqueous 
solution, shown an evolution similar to that verified for the measurements performed after 
removing a volume of solution similar to the agar-agar mass (figure 23). The resistance values 
with full volume were lower than the ones with the adjusted value, which is related to the 
larger contact surface presented by the agar-agar mass to the solution when the liquid level is 
higher. 
 
Reactance vs. Conductive volume  
(With corrected liquid content) (With the total liquid content of 250 mL) 
  
Average standard error of the mean = 9.6 Ω Average standard error of the mean = 10.5 Ω 
 
Figure 24) Phantom reactance as a function of the conductive volume for measurements after adjustment of the 
liquid volume (left) and with the total liquid content of approximate 250 mL (right). 
 
Although reactance has shown a slight tendency to become more positive with the 
volume (figure 24), the results were not conclusive when studying each phantom individually. 
An odd observation was made when examining the reactance values from phantom 2, since at 
100 kHz the aqueous solution shown an inductive behavior (X>0 Ω) (table 7), which would 
propagate to the measurements with the agar-agar volumes. This was verified only on this 
phantom, on the initial measurement inside the phantom container and on the final 
measurement as well, but not on the measurements on the 20 mL samples. The cause of such 
behavior is not clear, but it seems to have introduced an offset on the reactance values 
relative to the phantom 1, dislocating them closer to zero. The uncertainty values presented 
on figure 24 are close to the absolute value of the average reactance, capturing the 
incongruence between the two phantoms at this point. 
 
In general, the evolution of resistance and reactance of this biological material with 
the excitation frequency was in accordance to the expected (section 2.2). The resistance varies 
inversely with the excitatory frequency, since the energy of the signal increases at high 
frequencies making it easier to cross the material interfaces. The system components seem to 
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present an overall capacitive behavior with negative reactance, as verified by the preliminary 
tests on the 20 mL samples. In this case the reactance absolute value varies inversely to the 
frequency, i.e. the negative value becomes closer to zero with the increase of frequency. The 
reactance evolution is related to the material behavior at higher frequencies being similar to a 
capacitor, which approaches a short circuit – small opposition to the current flow - with 
increasing frequency (section 2.2).  
The impedance values for different phantoms did not overlap precisely and some 
odd events were spotted, but the overall direction of the impedance variations was coherent. 
Some anomalies might be related to the method intrinsic limitations imposed by the weighting 
scale and volumetric material. Furthermore, the agar-agar for food applications is not driven to 
this type of applications and can easily create structures with altered densities which effect 
cannot be easily described.  
The registered variations of impedance, from one measurement to another, could 
not be successfully related to the variation of volume for consecutive measurements – a 
limitation of using a static phantom that presents very discontinuous values. Based on the 
linear variation of resistance with the variation of the agar-agar volumes in both phantoms, 
can be concluded although that the overall impedance (real component) of the phantom 
decreases with the volumetric increase of its most conductive component, as expected.
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Throughout this chapter the system developed to perform ICG monitoring will be 
presented.  
The Arduino® microcontroller board is introduced as a part of the hardware. The 
basic operation of the AD5933 – integrated impedance meter – is explained in order to 
understand the need to adapt it to the ICG demands, namely: current injection and voltage 
sensing through high impedance inputs using a tetrapolar electrode configuration, DC bias 
elimination and small impedance measurement. The circuit developed to answer such 
needs is presented then, as well as the calibration process with its intrinsic limitations. The 
commercial ECG front-end operation is also explained. 
The firmware intercom with the hardware and the Matlab® GUI, which allows the 
control of the acquisition procedure, is explained. 
The Matlab® GUI and its capabilities are then presented. 
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The developed ICG system includes the hardware to acquire impedance and ECG 
signals, the firmware to control the data collection and the software interface to initially define 
the operation parameters and display the relevant data returned after basic pre-processing 
(figure 25).  
 
 
Figure 25) ICG system: simplified functional diagram describing the information flow between software, firmware 
and hardware. 
 
 Hardware 
The ICG system’s hardware can be subdivided into three main units: the impedance 
meter module, the ECG module and the microcontroller board that interacts with the other 
modules and runs the firmware for handling the data collection. The main focus of this work 
was to develop the impedance meter module, while the ECG acquisition was encompassed 
with a simple commercial front-end. 
 
 
Current 
injection
Voltage 
sensing
ECG unit
Definition of 
operation  
parameters
Graphical 
display
HARDWARE
Matlab® GUI
AD5933 Signal Conditioning
Arduino® 
microcontroller 
board
FIRMWARE
SOFTWARE
Signal parameterization and 
synthesis
ADC
Digital Signal 
Processing
Impedance meter unit
I2C
Analog input
USB
Chapter 4: Impedance Cardiography Acquisition System 
39 
 
 Arduino® Mega 2560 – microcontroller board 
The Arduino® Mega 2560 board (figure 26) includes several resources that were 
employed in this system. The board is clocked internally at 16 MHz. The I2C interface allows the 
communication with the integrated impedance analyzer (AD5933) at 400 kHz. The on-board 10 
bit, 9.6 kSPS ADC samples the ECG signal between 0-5 V delivered at one of its analog inputs. 
The microcontroller handles the data acquisition from the ECG and impedance units and its 
serial communication to the PC at 115.2 kBPS, via USB. The board is supplied with 9 V through 
a power pin and converts it internally to 5 V, the working voltage. It also supplies the AD5933 
with 3.3 V. The digital pins were only used for test purposes.  
 
 
Figure 26) Arduino® Mega 2560 board relevant components. 
 
4.1.2.  Impedance meter unit 
The impedance meter unit was built around an integrated impedance spectrometer, 
the AD5933 from Analog Devices. This chip was associated with an extension circuit in order to 
perform the medium excitation using an AC-current and the voltage sensing through high 
impedance inputs, in a tetrapolar electrode configuration, while adjusting the system to 
operate inside the limits for human safety. 
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4.1.2.1.  AD5933 - Integrated impedance analyzer 
 
Figure 27) AD5933 simplified functional block diagram depicting its basic operation configuration. 
 
The AD5933 [62, 63] is a fully integrated impedance measurement system (figure 27) 
configurable through a low level I2C serial interface [64]. In its basic configuration, the AD5933 
can measure impedance values from 100 Ω to 10 MΩ, with an accuracy of 0.5 %, for excitation 
frequencies from 1 kHz to 100 kHz, with a frequency resolution down to 0.1 Hz [62]. The 
operation procedure consists on exciting an unknown complex impedance (Zload) with a known 
controlled voltage and frequency, then measuring the current flowing through it to compute 
its complex (real and imaginary) Discrete Fourier Transform (DFT) coefficients in order to 
obtain the Zload components. The measurement can be repeated for the desired excitation 
frequencies by commanding the I2C interface. The system is typically applied to perform 
spectroscopic analysis using a frequency sweep, but a single frequency operation can be 
achieved programmatically. 
The voltage generation stage of the AD5933 includes a programmable direct digital 
synthesis (DDS) core that numerically synthesizes a sinusoidal signal at a defined frequency 
[65], converted by a digital-to-analog converter (DAC) into an analog waveform. The analog 
output undergoes a programmable gain stage that defines the peak-to-peak value of the 
output excitation signal made available at the VOUT pin, centered on a typical positive DC bias. 
The output impedance of the AD5933 at the maximum peak-to-peak voltage (1.98 Vp-p) is 200 
Ω. 
The current signal generated across Zload is forwarded to a current-to-voltage 
amplifier, in the current measurement stage, presenting at the VIN pin a virtual ground with a 
DC value set to half the supply voltage (VDD/2). The current flows into VIN developing a 
voltage signal at the amplifier output, with a gain externally defined by the feedback resistance 
(RFB), connected between RFB and VIN. The programmable gain amplifier (PGA) that follows, 
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allows the multiplication of the output by a factor of 1 or 5. The signal is low pass-filtered by an 
antialiasing filter and then presented to the input of a 12 bit, 1.04 MSPS analog-to-digital 
converter (ADC), that passes the digitalized results to the digital signal processing (DSP) engine. 
The RFB value and the PGA gain must be selected in order to maintain the signal within the 
linear range of the ADC (0V to VDD). The delay (Δtsettling) between the moment the DDS core is 
commanded to generate a waveform at specified frequency (f) and the time the ADC starts 
sampling a new impedance point (equation 11) is defined by the number of settling time cycles 
(Ns) programmed into the device. 
 ∆𝑡𝑠𝑒𝑡𝑡𝑙𝑖𝑛𝑔 =
1
𝑓
× 𝑁𝑠 ( 11 ) 
The system clock, for the DDS and ADC, is generated by the internal oscillator with a 
typical frequency of 16.776 MHz or, otherwise, provided externally.  
The multiply accumulate (MAC) core performs the DFT over 1024 samples, at each 
frequency, to determine the spectral power of the measured current. The calculation is based 
on the algorithm described by equation 12, where X(f) is the power of  the signal at the 
frequency f, x(n) is the ADC output and cos(n) and sin(n) are sample vectors provided by the 
DDS core at the frequency f, that carry information related to the output excitation signal. 
 
𝑋(𝑓) = ∑ (𝑥(𝑛) × (𝑐𝑜𝑠(𝑛) − 𝑗𝑠𝑖𝑛(𝑛)))
1023
𝑛=0
 ( 12 ) 
 
The real (R) and imaginary (I) components of the result, at each frequency, are stored 
in memory, encoded in the two’s complement format and the data registers can be accessed 
through the I2C interface. These are not the resistive and reactive components of the 
impedance under test: the DFT coefficient is an image of the complex input current and for 
that reason is inversely proportional to the (amplitude) value of the unknown impedance. The 
non-calibrated values of amplitude and phase (in radians) are computed using equations 13 
and 14. 
 
𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 = √𝑅2 + 𝐼2 
( 13 ) 
 
 
𝑃ℎ𝑎𝑠𝑒 =  𝑡𝑎𝑛−1 (
𝐼
𝑅
) ( 14 ) 
 
When using the arctangent formula to calculate the phase at each point the correct 
phase angle is returned only when the sign of the R and I components are both positive. To 
obtain the standard phase angles taken counterclockwise from the positive real x-axis the 
corrections in table 8 must be applied. 
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Table 8) Corrected phase angles [62]. 
Real component Imaginary component Quadrant Correct phase angle 
Positive Positive First 
 𝑡𝑎𝑛−1 (
𝐼
𝑅
) 
Negative Positive Second 
 𝑡𝑎𝑛−1 (
𝐼
𝑅
) + 𝜋 
Negative Negative Third 
 𝑡𝑎𝑛−1 (
𝐼
𝑅
) + 𝜋 
Positive Negative Fourth 
 𝑡𝑎𝑛−1 (
𝐼
𝑅
) + 2𝜋 
 
4.1.2.1.1. Calibration procedure and impedance 
calculation 
The AD5933 requires an initial calibration process, in which a known resistor (Rcal) is 
placed between VOUT and VIN and two corrective factors for the amplitude – gain factor - and 
phase – system phase - are calculated for subsequent measurements. The Rcal value should be 
a midpoint of the impedance range of interest to account for the gain introduced by the ratio 
of RFB/Zloud (ideally unitary gain). The gain factor is obtained from the Rcal value and the raw 
amplitude returned by equation 13, through the following expression. The gain factor is 
affected by the RFB value, the output excitation voltage, the PGA gain and the frequency.  
 
𝐺𝑎𝑖𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 =
1
𝑅𝑐𝑎𝑙 × 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
 ( 15 ) 
The phase measured by the AD5933 accounts the phase introduced across the whole 
signal path, along with the phase through the analyzed impedance. When a purely resistive 
load is placed at the AD5933 terminals the phase measured is completely due to the internal 
influence of the system components (equation 16). 
 𝑆𝑦𝑠𝑡𝑒𝑚 𝑝ℎ𝑎𝑠𝑒 = 𝑃ℎ𝑎𝑠𝑒, 𝑤ℎ𝑒𝑛 𝑍𝑙𝑜𝑎𝑑  𝑖𝑠 𝑝𝑢𝑟𝑒𝑙𝑦 𝑟𝑒𝑠𝑖𝑠𝑡𝑖𝑣𝑒. ( 16 ) 
After calculating these parameters, the true amplitude (|Zload|) and phase (Ɵload) of 
any unknown impedance are obtained using the following expressions, where amplitude and 
phase refer to the raw values obtained at each measurement from equations 12 and 13, 
respectively. 
 
|𝑍𝑙𝑜𝑎𝑑| =
1
𝐺𝑎𝑖𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 × 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
 
( 17 ) 
 
 
𝜃𝑙𝑜𝑎𝑑 = 𝑃ℎ𝑎𝑠𝑒 − 𝑆𝑦𝑠𝑡𝑒𝑚 𝑃ℎ𝑎𝑠𝑒 
( 18 ) 
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4.1.2.1.2. Operation parameters 
The typical values adopted for the operation of the AD5933 in the present system are 
specified in table 9, the details about their definition process are given in the firmware section, 
4.2. 
 
Table 9) AD5933 operation parameters – typical values. 
Power Supply 3.3 V 
Output signal frequency 50 kHz, 70 kHz or 100 kHz 
Output peak-to-peak voltage 1.98 Vp-p 
PGA gain 1 
Number of settling time cycles 5 
System Clock 16.677 MHz internal clock 
 
4.1.2.2. Signal conditioning circuit 
The AD5933 has been used in biological applications to perform electrical 
bioimpedance spectroscopy [66, 67, 68, 69, 70] and also ICG single frequency measurements 
[49]. 
Several circuit extensions to the AD5933 are proposed in the literature to adapt the 
chip to different purposes: allow the measurement of impedances connected to the ground 
[71]; allow the operation in a tetrapolar configuration [66, 68, 70, 49]; extend the impedance 
measurement range [67, 72, 73]; perform the load excitation using a current signal [72]; 
remove the signal DC bias to prevent electrolysis on biological tissues [74].  
In the present case, the changes to the normal operation of the AD5933 were made 
in order to complete the following requirements: 
 Convert the voltage excitation signal at the AD5933 output into a current encoded 
signal obeying to the ICG guidelines (section 2.4.1); 
 Minimize the output DC bias current to avoid the medium polarization (section 2.4.1);  
 Allow the use of a tetrapolar electrode configuration to reduce the influence of 
parasitic impedances from the interface electrode-skin (section 2.5); 
 Enable the measurement of impedances in the ICG range of interest (Appendix A); 
The extension circuit removes the DC voltage bias from the AD5933 output and feeds 
the signal to a voltage controlled current source (VCCS) that pursues the voltage-to-current 
conversion. The DC residual currents at the VCCS output are minimized by an AC-coupling 
circuit before the signal is delivered to the biological medium. The instrumentation amplifier 
senses the voltage differential generated across such impedance through high impedance 
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inputs and restores the DC component required for the AD5933 operation. The voltage output 
is converted to current by a series resistor. 
For the complete presentation of the impedance meter circuit please refer to 
Appendix C. 
 
Figure 28) Signal conditioning circuit. Current injection and voltage sensing electrodes are presented in green and 
blue, respectively. 
 
The first stage of the conditioning circuit (figure 28) encompasses a passive high pass 
filter, with a cutoff frequency of 3.4 Hz, which removes the typical DC bias from the AD5933 
voltage output signal. To buffer the filter output – as well as for the other buffers on board - 
the TLC074 [75] operational amplifier with low input noise and high input impedance was 
employed, preventing currents from flowing from the ground.  
The voltage-to-current conversion stage is based on the OPA860 VCCS [76]. It 
presents three terminals: a high impedance input (base, B), a low impedance input/output 
(emitter, E) and a current output (collector, C). In the presented configuration, the VCCS 
operates as a second generation positive current conveyor [77]: the input voltage applied on 
the input B is conveyed to E and the current generated through the emitter resistance (RE) is 
conveyed to the C output. If B presents a positive voltage relative to E, the current flows out of 
the C output, otherwise if B presents a negative voltage relative to E, the current flows into the 
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C output, more explicitly a current flowing out of E will generate a current flowing out of C. The 
VCCS is non-inverting because of the sense of the output current.  
In accordance to Ohm’s law, the theoretical amplitude of the output current (iC) can 
be obtained by multiplying the amplitude of the input voltage (vB), ideally half the peak-to-
peak voltage output defined for the AD5933, for the RE value. Following this, the RE value was 
chosen in order to generate an excitation current with typical amplitude of 1.94 mA, in 
accordance to the ICG typical current limits. 
The adjustment of the external resistor (RiQADJ) allows optimization of bandwidth, 
quiescent current and voltage-to-current gain trade-offs of the VCCS. The reduction of the 
quiescent current, by means of a large RiQADJ value, increases the output impedance at C, which 
minimizes the current variation for a range of impedance loads. This is an important point 
since the system correct operation relies on the precise current maintenance. The effect of a 
low quiescent current on the bandwidth is not relevant for the frequency range of interest.  
The inclusion of a DC-blocking capacitor (CDCBlocking) at the VCCS output is mandatory, 
in order to prevent applying DC currents into the subject.  This capacitor along with the 
impedance of the next stage forms a high pass filter, performing a passive AC-coupling 
process.  An intrinsic problem to bioimpedance measurements is the charging of the DC-
blocking capacitor due to residual DC currents related to electrode polarization, causing the 
saturation of the source output. To overcome this problem a DC feedback loop was 
implemented around the VCCS, following a principle widely described for similar systems [58, 
78, 79]. The voltage at the DC blocking capacitor output is sensed and low pass filtered at 30 
Hz with a passive filter to extract the DC component that is fed back into the VCCS emitter. 
This originates at the collector a current contrary to the one causing the DC-bias sensed 
voltage in the first place. The circuit performs an active correction of the DC component 
maintaining the output close to 0 mA. 
The current applied to the load, through the high current electrode, is then 
recovered at the low current electrode that conduces it across a grounded resistor (Rground). 
The Rground was included to maintain a stable VCCS output current, which occurs for load 
impedances higher than 390 Ω (section 5.1).  The voltage generated across the load, in 
response to the applied current, is sensed through the receiving electrodes at the high 
impedance input pins of the AD8220 instrumentation amplifier [80]. Since near no current 
passes through these electrodes the parasitic effect of the electrode-skin interface in the 
voltage measurement is minimized.  The high CMRR - near 60 dB for the frequency range of 
interest – minimizes common mode interferences, discounting the effect of any DC residual 
component that may arise. The AD8220 was used with unitary gain. The differential AD8220 
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output is referenced to 1.65 V, to repose the DC bias obeying to the AD5933 requirements. 
The reference is generated by an auxiliary circuit that provides ±3 V to the terminals of a 
variable resistor allowing the trimming of the required voltage. 
The voltage output from the AD8220 passes through the series resistance (Rseries) 
generating the current fed to the AD5933. In order to pass the voltage signal with unitary gain 
through the AD5933 current –to-voltage amplifier, the values of feedback resistance (RFB) and 
Rseries are equal. The value of Rseries was choose to maintain the current generated across this 
resistor by the voltage output of the AD8220 (with amplitudes in the range of 0-1.65 V), inside 
the interval of currents expected to be generated by the defined AD5933 voltage output across 
the range of impedances it can measure in its original configuration (section 4.1.2.1). For 
Zload=10 Ω, the relation between the voltage output and current input of the AD5933 - 
considering the ideal current output from the VCCS and the ideal voltage output from the 
AD5933 - results on a resistance of 0.5 MΩ, for Zload=815 Ω, the resistance seen by the AD5933 
is 6.3 kΩ. 
The particularities of this system made necessary the development of an adjusted 
calibration process. 
 
4.1.2.2.1. Calibration procedure revised and impedance 
calculation 
By injecting a current and sensing a voltage the extension circuit introduces an 
admittance in the signal path, i.e. considering a constant excitation current, if |Zload| increases 
the AD8220 output voltage will also increase, producing a higher current across Rseries, and the 
reciprocal. This is not taken into account in the original calibration process, since the normal 
operation of the system expects a current drop in response to an increase in |Zload|.  
The AD5933 sees the extension circuit as a complex impedance and the current 
generated across Rseries, in response to the voltage output of the AD8220, is acquainted as the 
response of the complex impedance to the excitation voltage at VOUT. This way the variation 
of the AD8220 voltage output is seen by the AD5933 as a variation in the Rseries value. 
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Figure 29) Simplified impedance unit with relevant quantities and simplified presentation of stray components 
equivalent (Ze). 
 
The impedance value (Z), as seen by the AD5933, is the relation between the voltage 
output (Vout) and the current input (iin) given by the Ohm’s law. Based on the analysis of this 
relation some conclusions can be drawn with respect to the load impedance value (Zload). 
The deduction presented below (equation 19) assumes that the current output is 
constant and equal to the theoretical value defined by the emitter resistor (RE) and considering 
that no current is deviated from its path across the load (figure 29). The AD8220 voltage 
output (VAD8220) is considered to be the linear result of the ideal current output of the VCCS 
passing across the load, in accordance to the defined gain (GAD8220). 
 
𝑍 =
𝑉𝑜𝑢𝑡
𝑖𝑖𝑛
=
𝑉𝑜𝑢𝑡
𝑉𝐴𝐷8220
𝑅𝑠𝑒𝑟𝑖𝑒𝑠
=
𝑉𝑜𝑢𝑡
𝑖𝐸 × 𝑍𝑙𝑜𝑎𝑑 × 𝐺𝐴𝐷8220
𝑅𝑠𝑒𝑟𝑖𝑒𝑠
=
𝑉𝑜𝑢𝑡
𝑉𝑜𝑢𝑡 × 𝑍𝑙𝑜𝑎𝑑 × 𝐺𝐴𝐷8220
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠
 
=
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠
𝑍𝑙𝑜𝑎𝑑 × 𝐺𝐴𝐷8220
 
( 19 ) 
 
The estimative of the load impedance (Zload) is given by rearranging the last 
expression. 
 
𝑍𝑙𝑜𝑎𝑑 =
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠
𝑍 × 𝐺𝐴𝐷8220
 ( 20 ) 
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AD5933
HPF
CDCblock
Zload
OPA860
Rground
B
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E
RE
LPF
RG
Rseries
Rfb
Vout
Vin
Ze
Ze
Ze
Ze
idev=0
Z
iin
idev=0
iload=iE
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Unrolling the expression into its complex exponential representation gives a better 
understanding of the relation between amplitude and phase of the measured impedance, Z 
and Zload. 
 
|𝑍𝑙𝑜𝑎𝑑|𝑒
𝑗𝜃𝑙𝑜𝑎𝑑 =
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠
𝐺𝐴𝐷8220
×
1
|𝑍|𝑒𝑗𝜃
 ( 21 ) 
 
The comparison of both sides of the expression leads to the following relations. 
 
|𝑍𝑙𝑜𝑎𝑑| =
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠
𝐺𝐴𝐷8220
×
1
|𝑍|
 
( 22 ) 
 
 
𝑒𝑗𝜃𝑙𝑜𝑎𝑑 = 𝑒−𝑗𝜃 ⇔ 𝜃𝑙𝑜𝑎𝑑 = −𝜃 
( 23 ) 
 
This principle can be applied to correct the calibration process and the outputs 
during general acquisition, as follows.  
 
Based on the equation 22, the relation between the calibration resistance (Rcal) and 
the amplitude of the impedance perceived by the system (Zcal) can be obtained as follows. 
 
|𝑍𝑐𝑎𝑙| =
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠
𝐺𝐴𝐷8220
×
1
𝑅𝑐𝑎𝑙
 ( 24 ) 
 
The gain factor for the amplitude can then be derived similarly to the original 
procedure (equation 15). 
 
𝐺𝑎𝑖𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 =
𝑅𝑐𝑎𝑙 × 𝐺𝐴𝐷8220
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠 × 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
 ( 25 ) 
 
The system phase can still be considered to be the phase perceived by the system 
with a purely resistive component at its terminals (equation 16), with all the stray 
contributions across the system resulting in a constant value at a given frequency. 
 𝑆𝑦𝑠𝑡𝑒𝑚 𝑝ℎ𝑎𝑠𝑒 = 𝜃𝑐𝑎𝑙 
( 26 ) 
 
The system phase is determined from the raw real and imaginary values, simply by 
applying the arc tangent expression (equation 14). 
 
During acquisition the corrected amplitude and phase values are accessed based on 
the following expressions. The calibrated amplitude of the impedance is obtained by 
substituting the perceived impedance amplitude value |Z| given by equation 17 on equation 
22. The common factors from |Zload| and the gain factor expression (equation 25) could be 
simplified, resulting on expressions not dependent on the RE, Rseries and GAD8220, although, they 
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are presented in the form they were implemented in practice. The calibrated impedance phase 
is the combination of equation 18, the original phase, and equation 23.  
 
|𝑍𝑙𝑜𝑎𝑑| =
𝑅𝐸 × 𝑅𝑠𝑒𝑟𝑖𝑒𝑠
𝐺𝐴𝐷8220
× 𝐺𝑎𝑖𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 × 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 
( 27 ) 
 
 
𝜃𝑙𝑜𝑎𝑑 = −𝜃 ⇔ 𝜃𝑙𝑜𝑎𝑑 = 𝑆𝑦𝑠𝑡𝑒𝑚 𝑝ℎ𝑎𝑠𝑒 − 𝑃ℎ𝑎𝑠𝑒 
( 28 ) 
 
From the impedance amplitude and phase the resistance (Rload) and reactance (Xload) 
values can be calculated using the general expressions, as follows. 
 
𝑅𝑙𝑜𝑎𝑑 = |𝑍𝑙𝑜𝑎𝑑| × 𝑐𝑜𝑠 (𝜃𝑙𝑜𝑎𝑑) 
( 29 ) 
 
 𝑋𝑙𝑜𝑎𝑑 = |𝑍𝑙𝑜𝑎𝑑| × 𝑠𝑖𝑛 (𝜃𝑙𝑜𝑎𝑑) 
( 30 ) 
 
 
4.1.2.2.2. Calibration procedure assumptions and 
limitations 
The calibration process formulized above relies on assumptions that must be 
justified. Also, the practical implementation of the calibration process will suffer from 
approximations that have to be analyzed. 
The high pass filter, the VCCS, the DC blocking capacitor, the cables and the 
instrumentation amplifier, as well as the stray impedances along the current path were 
considered to introduce systematic errors on the impedance measurement at a specified 
frequency. Therefore they are accounted for in the values of the calibration parameters. The 
calibration model also considers a constant current supplied by the VCCS , flowing across the 
path to the ground, without any deviation that can cause the current that flows on the load 
(Zload) to be different from the ideal VCCS output.  
The parasitic impedances that affect the impedance measurement in the specific 
case of the ICG are presented on figure 30. The blocks represent complex impedances: the 
electrode-skin interface is described by the circuit presented on section 2.5.2, while the 
remaining can be identified with the RRC parallel circuit (section 2.2). 
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Figure 30) Equivalent electric circuit of all parasitic impedance components affecting the thoracic impedance 
measurement (Zchest) [58, 66]: Zcables corresponds to the effect of the electrode cables; Ze-s is the electrode-skin 
interface impedance; Ztissue represents the tissue in between the application and sensing electrodes.  
 
The sensing electrodes high input impedance prevent the current from flowing 
through them, as explained before (section 2.5). In this particular case, the influence of the 
interface electrode-skin, as well as the cables parasitic capacitances have very low impact on 
the impedance measurement.  
There are evidences that the electrode-tissue interface acts as a resistor at 
frequencies higher than 10 kHz [81]. The high impedance amplitude on the application 
electrodes can have significant impact on the precision of the system because it can affect the 
VCCS output, while increasing the common mode voltage at the instrumentation amplifier 
input [66]. 
The stray capacitances introduced by the cables are especially important in the 
application electrodes where the current flows. Their influence would probably be reduced by 
using a driven shield technique - not employed in the present system. Nevertheless, the effect 
of this protection is only evident at high frequencies (> 105 Hz) [58], revealing a little impact in 
the frequency range of this system.  
The capacitive leakage is a deviation of the reactance value mainly observed at high 
frequencies, although, it affects the impedance value at every frequency. This effect is cause 
by parasitic capacitances (Cstray) primarily introduced by amplifiers and can be described by a 
capacitor in parallel to the load (figure 30). Parasitic capacitances in general introduce 
systematic errors in the impedance measurements - they can also be accounted by the 
calibration factors - and their influence does not drastically affect the impedance analysis at a 
single frequency. 
 
Ze-sZe-s Ze-sZe-s
Cstray
ZcablesZcables ZcablesZcables
Ztissue ZtissueZchest
 -   V(t)   +
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During the practical implementation of the calibration procedure the spot electrode 
pads (section 4.1.4) cannot be used, that way the calibration resistor - with a value similar to 
the thoracic impedance - is directly connected between the metallic plugs at the electrode 
cable endings. This process accounts for the cable influences, but not for the electro-skin 
interface, neither for the effect of the inter-electrode tissue. The reliability of such calibration 
procedure is dependent on the VCCS compliance, which will define the variation of the current 
output with the extra impedance component. Also this procedure assumes that the calibration 
parameters are mainly affected by the amplitude of the load between the instrumentation 
amplifier terminals, which defines the leakage through the stray capacitance and produces the 
most important contributions on the system gain variation through the voltage drop produced. 
The acquaintance of the equivalent model for the stray impedances was important to 
understand their effect on the impedance measurement. Although, the incomplete knowledge 
of the model components and the lack of a reference tetrapolar method to establish 
comparisons with, made the development of a test circuit based on this model unreliable.  
 
4.1.3. ECG unit 
The ECG unit is based on a commercial analog front-end that senses, amplifies and 
filters the ECG waveform, including an on board 50 Hz notch filter to remove the line noise in 
accordance to the European constraints. The output placed between 0 and 5V is directly 
forwarded to an ADC. The ECG electrodes are connected to 3 inputs: R, right; L, left and G, 
ground. The ground electrode is directly connected to the circuit ground.  
The three electrodes are placed one at each arm and one on the right leg, forming 
the edges of the Einthoven’s triangle (figure 31). The ECG records the differential voltage 
between any two points of the triangle. In this procedure three different leads are obtained: 
Lead I is measured between the left arm (+) and the right arm (-); Lead II is measured between 
the right leg (+) and right arm (-); Lead III is measured between the right leg (+) and the left 
arm (-). [18]. 
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Figure 31) ECG front-end [82] and the 3-lead ECG configuration. 
 
This ECG front-end presented some problems, when performing measurements by 
itself - without ICG – it would saturate when all the three electrodes where connected to the 
subject, but performed well while only lead I was measured. 
 
4.1.3.1. ECG calibration method 
The Arduino® ADC has a resolution of 10 bits, returning values from 0 to 1023 at each 
reading. The simplest way to obtain the physical quantity from these values is by using the 
following expression, assuming a constant supply voltage (Vcc). 
 
𝑉(𝐸𝐶𝐺) =
𝐴𝐷𝐶𝑣𝑎𝑙𝑢𝑒 × 𝑉𝑐𝑐
1023
 ( 31 ) 
 
The value returned directly from the ADC is referenced to the 5V supply pin on 
board.  The referred voltage was measured during acquisitions resulting in an average value of 
5.05 ±0.01 V.  Fluctuations in the supply voltage imply that at each sampled point measured 
the reference value can be different, for such, the overall correction considering a constant 
value of Vcc is an erroneous process. Since the ECG amplitude is not evaluated during ICG 
measurements it was considered the average supply voltage to perform the correction.  
 
4.1.4. Electrode construction 
The system needs 4 ICG electrodes – high current (I+), low current (I-), high voltage 
(V+), low voltage (V-) - and 3 ECG electrodes – right arm (R), left arm (L) and ground (G) -  for 
its operation.  
ADC
(Arduino®)
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Figure 32) ICG (left) and ECG (right) electrode components:  (1) plug for connection with the device, (2) plug for 
connection with the subject and (3) plug adapter for clip electrodes. 
 
To optimized signal-to-noise ratio coaxial cables were employed in both cases. The 
ICG electrodes were constructed using 1 m long RG178 RF coaxial cables (Ø=1.8 mm, maximum 
resistance=8.02 Ω/m and capacitance=98 pF m-1). The ECG electrodes employed RG174 RF 
coaxial cables (Ø=2.794 mm and capacitance=101 pF.m-1) also with 1 m. To eliminate 
interferences the input of the shield conductor was grounded - except for the ECG ground. 
Simply grounding the shield might have been a poor solution, since for long cables the 
capacitance between the shield and the core remains, living the input signal vulnerable to 
interference. Such stray capacitance can attenuate the high frequency component of the input 
signal - more relevant to the ICG electrodes. The driven shield input partially cancels the 
capacitive effect, by putting both conductors at the same potential [83]. The plugs employed 
for each type of electrode are depicted in figure 32. 
 
 
Figure 33) Pre-gelled disposable electrodes for ECG. 
 
The electrode contact with skin was made through 48×50 mm pre-gelled disposable 
foam electrodes for ECG (F9060 from FIAB). 
 
❶ 
❶ 
❷ 
❸ ❸ 
❷ 
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4.1.5. Printed Circuit Board Specifications 
The circuit was included on a 16×10 cm printed circuit board (PCB) (figure 34), 
designed to satisfy the specifications of an already existing platform.  
  
Figure 34) PCB board (midle) mounted on a test platform with voltage converting module (left), showing the 
frontal panel with sockets to connect the electrodes and the Arduino® board on the PCB back, and multichannel 
platform (right). 
 
The multichannel platform (figure 34) has the purpose of operate several 
hemodynamic probes at once. This platform presents various slots were each costume made 
circuit board can be accommodated and plugged into a bus communication system that 
provides the power supply to the board and encompasses analog pins, digital pins and USB 
channels to establish the communication with external devices. During all the ICG system trials 
a test platform, analog to the multichannel platform, was used. The test platform is supplied at 
12 V by an external voltage source and an intermediate circuit performs the voltage 
conversion to supply ±5 V and ±15 V to the board. The developed ICG system only uses the bus 
for power supply. 
 
4.2.  Firmware 
The firmware that runs on the Arduino® microcontroller is triggered by a serial input 
from the user interface (GUI) sent via USB (figure 35). The inputs from the GUI are sent in a 
fixed order, along with an 8 bit identifier value.  The Arduino® code waits until he receives a 
known 8 bit sequence, reads the parameter value associated with such identifier and in return 
sends the correspondent confirmation character to the GUI.  The communication proceeds if 
the identifier and the confirmation character correspond to the values expected on either side.   
The input parameters result from user definitions that need to be programmed into 
the firmware to set the operation mode – acquisition or calibration -, the impedance meter 
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excitation frequency – 50, 70 or 100 kHz - and the sampling frequency – 400 Hz maximum. In 
calibration mode only the impedance meter output is acquired, whereas in acquisition mode 
the ECG input is also sampled.  
The initialization of the AD5933 is conducted following the steps on figure 35. Every 
time an impedance measurement is needed another request to the AD5933 has to be issued 
by programming a measurement repetition at the defined frequency. 
The sampling frequency is established by setting a timer to operate the data 
acquisition at fixed periods. The minimum acquisition period (2.5 ms) was drawn based on the 
time elapsed between two valid measurements, which was evaluated in 1.879 ms (maximum). 
This evaluation was made by setting a digital pin high during the time a measurement took 
place – which includes the time for sending a measurement request to the AD5933, waiting till 
the measurement is available, read it and send the result to the serial interface, reading the 
analog input from the ECG front-end and send the result to the serial interface – and verifying, 
with the oscilloscope (Picoscope®), the time interval the digital pin was high. The code inside 
the timer was optimized so that the actual impedance point would be processed inside the 
AD5933 core in parallel to the ECG sampling/reading and red in the next cycle. This procedure 
also introduces a minimum delay between the time the AD5933 ADC starts sampling the 
impedance point and the moment the ECG point is sampled by the Arduino® ADC.  Although 
no problems were verified when using the maximum sampling rate, a backup was included. In 
case the measurement is not ready and the timer needs to ignore an acquisition, the data sent 
to the interface (zeros) will lead to a NAN value on the impedance data and a 0 in the ECG 
data, informing that the acquisition was not correct. 
The code inside the timer takes only 1.13 ms to run, in the remaining time the 
Arduino® verifies if there was a known finalization input from the GUI, if any the timer is 
turned down, so no more data is sampled and sent. Arduino® waits for another input from the 
GUI, meaning that all the data in the serial line was cleaned, and powers down the AD5933, 
extinguishing the excitation signal to the load. In a similar fashion as for initialization a 
confirmation character is sent to assure the effectiveness of the finalization. 
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Figure 35) Process diagram for the firmware operation.  
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4.3. Software 
The user guide interface (GUI) was developed using Matlab®. It allows the acquisition 
initialization, while giving control over some operation parameters, displays the raw results in 
real time and shows the pre-processed data at the end of each acquisition. In a similar way to 
the firmware, it can operate in one of two modes - ICG acquisition or calibration –, presenting 
some graphical differences in either cases. The operation mode is defined in a dedicated panel 
that also presents typical parameters for the chosen mode. 
 
 
Figure 36) Graphic User Interface after a measurement presenting the raw impedance and the ECG signals and 
the pre-visualization of pre-processed data: respiratory impedance, cardiac impedance, base impedance, ICG 
signal and ECG. 
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During ICG acquisition the GUI exhibits a control panel (figure 36 , left side) divided 
into 3 sections. The subject information section enables gathering basic information about the 
examined subject: in hospital setting other parameters would be relevant, but for the depth of 
the studies conducted this was enough. The system parameters section lets the user choose 
the serial port (COM) where the Arduino® board communication is established, the excitation 
frequency, the sampling specifications and the graphical presentation parameters. The time 
between updates defines how often Matlab® revisits the information in the serial interface, 
the limit is 1 s to prevent data from accumulate rendering the Matlab® operation slow. A 
cancel button is available during acquisition, giving the option to stop the acquisition, while 
the acquired data can still be saved if the user wishes to do so. 
When the acquisition process is initiated, after the initialization parameters are 
transferred, the data received at the serial port is converted to decimal values, then the raw 
amplitude and phase are calculated and calibrated. The calibration of the impedance data is 
implemented using a single pair of calibration parameters through the whole process. The 
calibration parameters can be obtained from a file generated on calibration mode that must 
be chosen by the user or by using an automatic procedure, in which case the first 10 s of data 
received are evaluated to verify the average raw amplitude value, used to calculate the 
calibration parameters based on established calibration models (section 5.3). This process and 
the initialization together account for an unreasonable waiting time that could not be reduced 
effectively. 
The calibrated impedance amplitude with no further processing and the calibrated 
ECG are presented in the graphic panel (figure 36 , right side) and updated periodically. The 
remaining impedance curves (phase, resistance and reactance) are also calculated in 
background. At the end of the acquisition the data can be saved in a .mat file.  
The pre-processed data can only be evaluated at the end of each measurement since 
the filtering is not applied in real time (section 6.1.3). 
 
In calibration mode the interface presents a simplified control panel (figure 37). After 
the data acquisition is initiated the data received is converted to decimal and the raw 
amplitude (equation 13) and phase (equation 14) are presented in the graphic panel. At the 
end of each acquisition the calibration parameters are calculated based on the average values 
of amplitude and phase. Such data can be stored in a calibration file prepared to be used 
during acquisition. 
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Figure 37) Graphic interface after acquisition of calibration data. 
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In this chapter the results from the system (described before) performance 
evaluation are presented.  
The current source was tested in its native state to verify its compliance and 
internal resistance in order to corroborate the assumptions made in the last chapter 
related to its operation. 
The AC and DC currents on board are examined to verify their accordance to the 
secure limits and the instrumentation amplifier measurement behavior is analyzed. 
The practical implementation of the calibration procedure and the errors it 
introduces were studied. The calibration models established from this study as well as the 
resulting automated calibration procedure are also evaluated. 
The process of estimation of the time delay introduced on the ECG signal by the 
filtering processes is also presented. 
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5.1. Current source evaluation 
In an ideal situation the system should be able to cope with body impedances till 1.5 
kΩ [77], taking into account the sum of stray impedances in the current path. Also, the current 
source compliance has a fundamental role in the system correct operation, since the 
impedance load may present variations during the measurement procedure and between 
subjects. This way the maintenance of the current value across a comfortable range of 
impedance loads is necessary. 
 
Figure 38) Voltage controlled current source (OPA860) basic configuration. B represents the base where an AC 
voltage is injected, E is the emitter where the current output is defined by the resistor RE and C is the collector 
where the current output is delivered to the load resistor (Rload). 
 
The VCCS compliance and internal resistance were evaluated at each working 
frequency of the ICG system for a set of load resistors (table 10) placed on the collector. The 
configuration employed is described on figure 38 and the tests were performed on bread 
board. The AC voltage on B was supplied by a signal generator and the average characteristics 
of the signal are described on table 11.  
 
Table 10) Test resistor (Rload) values for evaluation of the current source. The values cover all the working range of 
the current source. 
Rload (Ω) 10.2 50.8 99.4 149.4 196 388 466 508 685 815 1190 2390 
 
For every test resistor and for each excitation frequency the characteristics - 
frequency, peak-to-peak voltage (Vp-p), DC offset (VDC) - of the input voltage signal at B and 
output voltage signal at C were registered. The measurements were performed using the 
Picoscope® - PC oscilloscope - acquisition interface. 
 
Table 11) Signal generator output characteristics: frequency (F), peak-to-peak voltage (Vp-p) and DC offset (VDC). 
Average values on the input B from each the measurement performed on the test resistors. The error is 
evaluated in terms of the standard error of the mean.  
F (kHz) Vp-p (V) VDC (mV) 
50.20 ± 0.03 1.906 ± 0.002 79.41 ± 1.36 
71.68 ± 1.03 1.913 ± 0.002 77.96 ± 4.60 
103.38 ± 0.51 1.896 ± 0.004 79.74 ± 2.65 
 
OPA860
510   Rload
Vin B
C
E
RE
iload
iE
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To evaluate the source compliance, the amplitude (iload) and the DC bias (iloadDC) of the 
current across Rload were calculated from the measured AC (Vp-p) and DC (VDC) voltages at C as 
follows (equation 32 and equation 33 ). The results of such evaluation are presented below. 
 
𝑖𝑙𝑜𝑎𝑑 =
𝑉𝑝−𝑝
2 × 𝑅𝑙𝑜𝑎𝑑
 
( 32 ) 
 
 
𝑖𝑙𝑜𝑎𝑑𝐷𝐶 =
𝑉𝐷𝐶
𝑅𝑙𝑜𝑎𝑑
 ( 33 ) 
 
 
Mean (mA) 1.74 ± 0.02 
Maximum (mA) 1.85 
Minimum (mA) 1.58 
Figure 39) VCCS: current amplitude variation with the load resistance value. The vertical line represents Rload=388 
Ω. The statistic values consider only the stable region to the right of 388 Ω. 
 
The VCCS presents an acceptable AC compliance for load resistances higher than 388 
Ω (figure 39), with a near linear current response. Despite being different from the theoretical 
value, the current amplitude inside this stable region is in accordance to the ICG demands 
(<2.5 mA, section 2.4.1).  
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Mean (mA) 0.19 ± 0.01 
Maximum (mA) 0.27 
Minimum (mA) 0.09 
Figure 40) VCCS: DC bias variation with the load resistance value. The vertical line represents Rload=388 Ω. The 
statistic values consider only the stable region to the right of 388 Ω. 
 
The DC response of the VCCS (figure 40) presents the same initial instable behavior as 
for the AC evaluation. For resistances higher than 388 Ω, the DC current shows a linear 
behavior with the expected polarity for a positive DC input. The mean DC value is a conjoint 
result from the source input being dislocated from 0 V and the effect of the input bias current 
of the VCCS. These preliminary results are satisfactory though, because the DC output is inside 
the limits for human sensibility (<0.6 mA, section 2.4.1). 
 
The evaluation of the source internal resistance (Rin) was based on the expression for 
the current divider expression (equation 34), where ideal is the theoretical value of the current, 
obtained from RE and Vin by applying the Ohm’s law. Since the generator output value 
presented some variations the ideal value was calculated for each measurement, assuming RE 
constant. 
 
𝑅𝑖𝑛 =
𝑖𝑙𝑜𝑎𝑑 × 𝑅𝑙𝑜𝑎𝑑
𝑖𝑖𝑑𝑒𝑎𝑙 − 𝑖𝑙𝑜𝑎𝑑
 
( 34 ) 
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Mean (Ω) 1.36E+04 ± 1.27E+03 
Maximum (Ω) 3.76E+04 
Minimum (Ω) 9.32E+03 
Figure 41) VCCS: internal resistance variation with the load resistance value. The vertical line represents Rload=388 
Ω. For Rload<388 Ω the internal resistance is presented in module (absolute value). The statistic values consider 
only the stable region to the right of 388 Ω. 
 
The mean source internal resistance (figure 41) inside the stability region is 
approximately one order of magnitude higher than the larger load resistance tested, which is 
an acceptable result. 
For load resistances lower than 388 Ω, the output current is higher than the ideal, 
rendering the denominator of equation 34 negative. The lowest the load resistor the better it 
approaches a short circuit and the less current is diverted through the source internal resistor, 
a behavior compatible with a high internal resistance. The current amplitude results (figure 39) 
are compatible with such line of thought presenting higher values of current through the load 
than for larger resistances. The accentuated decline of Rin for low Rload is an effect of the large 
absolute difference between the ideal and verified current on equation 34. Also should be 
notice that low Rload measurements suffered from higher noise levels which could have altered 
the results for those resistances. 
 
From this evaluation follows that the VCCS load impedance can reach 2.39 kΩ 
without occur the output saturation due to the voltage generated across the load. Also, the 
output current deviation from the ideal is acceptable and the source can maintain the same 
approximate current values for a significant range of resistors, permitting an accurate function 
of the ICG system and a correct implementation of the calibration procedure.  
To eliminate the devious behavior of the source for low resistors a grounded resistor 
of 390 Ω was placed in the current path. This resistor is especially relevant when measuring 
impedances directly placed on the system terminals and permits the accurate implementation 
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of the calibration procedure (as described on section 4.1.2.2.2). When dealing with a real ICG 
acquisition the impedance of the two electrode-skin interfaces in the current path alone 
(section 2.5.2) are enough to put the source inside the stable region. 
 
5.2. AC and DC performance and security limits 
The system circuit was evaluated on board to verify if the current values across a load 
at its terminals were appropriated for human safety. The evaluation was performed on 17 
resistors inside the operation range of the system (table 12), by placing them between the 
electrode plugs. The maximum resistor value was chosen by a trial and error process.  The AC 
and DC voltages were measured using the Picoscope® interface and the current components 
were calculated as before, using equations 32 and 33.  
 
Table 12) Test resistor (Rload) values. These resistors cover the full impedance measurement of the system.  
Rload 
(Ω) 
10.2 24.8 29.8 30 33 39.7 50.8 74.7 99.4 149.4 196 280 388 466 508 685 815 
 
The VCCS voltage input was also evaluated and the results are presented on table 13, 
showing acceptable accordance with the expected values and small variations. 
 
Table 13) VCCS voltage input characteristics on board: Frequency (F), peak-to-peak voltage (Vp-p) and DC offset 
(VDC). Average values from each measurement performed on the test resistors. The error is evaluated in terms of 
the standard error of the mean. 
F (kHz) Vp-p (V) VDC (mV) 
49.662 ± 0.003 1.951 ± 0.005 -95.47 ± 2.31 
69.532 ± 0.002 1.942 ± 0.006 -89.41 ± 1.98 
99.346 ± 0.007 1.929 ± 0.004 -90.20 ± 1.66 
 
Since the total impedance value across the current path could only be estimated, the 
measurements were performed right before the grounded resistor of 390 Ω. This 
approximation considers that the current output after the DC blocking capacitor that will flow 
through the load, will also pass through the grounded resistor. Nevertheless, a remark as to be 
done related to the current that might be deviated through the stray capacitance parallel to 
the load (section 4.1.2.2.2). This effect will decrease the current through the load causing this 
study to be affected by a systematic error for excess regarding the current calculation. This 
does not affect the purpose of the actual study, since the excess error only extends the 
security limits for the current, in case the evaluated values are inside the security range.  
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Mean (mA) 1.840 ± 0.009 
Maximum (mA) 2.168 
Minimum (mA) 1.772 
Figure 42) PCB: current amplitude through the grounded resistor of 390 Ω. 
 
All the registered current amplitudes (figure 42) are inside the range for ICG 
applications for this frequencies (<2.5 mA, as the most limitative value at 50 kHz, section 
2.4.1). In average the variation is not significant, the overall variation registered may in fact be 
related to noise. The maximum peak registered was due to a noisy signal that altered the 
Picoscope® evaluation. 
 
 
Mean (mA) -0.217 ± 0.002 
Maximum (mA) -0.189 
Minimum (mA) -0.272 
Figure 43) PCB: DC bias through the grounded resistor of 390 Ω. 
 
The DC bias on board (figure 43) is negative since the input DC component is also 
negative, although the polarity is not very important for this matter. This evaluation shows 
that the AC-coupling does not completely removes the DC bias, although the results are below 
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the limits for human sensibility (<0.6 mA in module, section 2.4.1) in all the measurements, 
with a comfortable gap. 
 
The current output after the blocking capacitor was also studied (Appendix D) based 
on an estimative of the total impedance load equal to the test resistance plus the grounded 
resistor value – also resulting in a systematic error for excess. The results were in average 
similar to the ones estimated based on the grounded resistor with no violation of the safety 
limits, producing an even larger gap from the safety limits. This data was not further studied 
since the first evaluation was considered more accurate.  
 
The reference of 1.65 V fed to the AD8220 was adjusted at the beginning of each 
measurement to the closest value possible and the average of the values throughout the 
measurement process was 1.638 ± 0.002 V. The instability of this reference has especial 
influence in the AD5933 evaluation of the current input and after being verified its instability, 
it was corrected at each measured performed. 
The calculation of the current from the instrumentation amplifier output was also 
attempted, although the results shown to be interesting, were unreliable for the current 
determination purposes. 
Considering the AD8220 unitary gain definition, the current amplitude value passing 
through the load would be the result of applying the Ohm’s law to the voltage output of the 
AD8220 (min = 0.144 Vp-p and max = 2.752 Vp-p in the range of resistors tested) and the load 
value in a similar way to equation 32. The result presented on figure 44 is not as linear as 
expected. This effect cannot be related to a current variation through the load as proven by 
the results of the current evaluation. The reason might be a non-linear behavior of the AD8220 
for small loads at its terminals that is probably related to the combination of the noise effects 
on the small signals and also to the effect of the (small) input bias currents. This point is 
supported by the lack of information on its datasheet [80] for measurements below 100 Ω.  
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Mean (mA) 2.8 ± 0.2 
Maximum (mA) 7.2 
Minimum (mA) 1.7 
Figure 44) PCB: Current amplitude as a result of applying the Ohm's law to the AD8220 output voltage and the 
actual load resistor value. 
 
The results from these evaluations were assumed to be kept when measuring the 
impedance on a real setup on a human. This is a good abstraction since the source shown a 
good maintenance of the current amplitude value and the circuit holds the capabilities to keep 
the DC component at low levels. Furthermore, the source output was later monitored during 
the system operation on a human subject at the minimum and maximum frequencies of 
interest to verify if the source would saturate or if any anomaly in the DC component would be 
verified. Since no anomalous result was verified the data was not further explored and the 
evaluations in this section were assumed as a good approximation. 
 
5.3. Calibration procedure evaluation 
In order to study the effectiveness of the proposed calibration procedure and 
attempt to reduce its limitations an exhaustive study of the effect of the excitation frequency 
and the Rcal value on the calibration parameters was made. The study resulted on the 
definition of models for the variation of calibration parameters that allowed the 
implementation of an automatic calibration procedure. The original calibration procedure used 
a pair of calibration parameters for each frequency based on the measurements on a single 
resistance. This was neither practical, nor reliable since it implied an approximation procedure 
for which the error could not be evaluated when dealing with a range of Zload values. The 
evaluation was performed on the same resistors (table 12) that were used for the current 
limits analysis. To avoid a biased analysis of the results, two data acquisitions of 60 s, at a 400 
1,5
2,5
3,5
4,5
5,5
6,5
7,5
8,5
0 200 400 600 800 1000
C
u
rr
en
t 
 a
m
p
lit
u
d
e(
m
A
)
Load Resistance (Ω)
AC current through the load as seen by the 
AD8220
50kHz
70kHz
100kHz
Chapter 5: System Evaluation 
70 
 
Hz sampling frequency, were performed on each resistor: one for calibration and one for 
evaluation. 
To evaluate the calibration process using a complex impedance a RRC circuit was 
developed, presenting amplitude and phase values fairly close to the thoracic impedance 
range (Appendix A). 
 
Table 14) RRC circuit for testing purposes and impedance characteristics.  
 
Frequency 
(kHz) 
Amplitude 
(Ω) 
Phase (°) Resistance 
(Ω) 
Reactance (Ω) 
50 23.451 -17.074 22.417 -6.886 
70 21.805 -14.026 21.155 -5.284 
100 20.766 -10.686 20.406 -3.851 
 
The non-calibrated amplitude (equation 13) and phase (equation 14) with the 
quadrant correction – system phase - were calculated point-to-point using the calibration data 
set, and the results were averaged for each test resistor at each frequency. The gain factor for 
the amplitude (equation 25) was calculated based on the averaged non-calibrated amplitude. 
The figure 45 shows a linear direct variation of the non-calibrated amplitude value - 
used to derive the gain factor - with the test resistor value.  Exhibiting a behavior compatible 
with an admittance: the raw amplitude is an image of the current input of the AD5933 – 
initially inversely proportional to Zload (section 4.1.2.1.1) – being directly proportional to the 
test resistance value (equation 27). The phase variation with the load resistance is not linear 
for small resistances and there is a clear variation of its value across frequencies. 
 
Non-calibrated amplitude and phase values 
  
 
Figure 45) Variation of non-calibrated amplitude (left) and phase - system phase - (right) with the test resistor 
value. 
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The calibration parameters were evaluated first on the test data set from the same 
resistors and then on the RRC circuit, to evaluated univocally the effectiveness of the algorithm 
on complex impedances. The calibrated impedance amplitude (equation 27) and phase 
(equation 28) were calculated point-to-point and averaged for each resistance at each 
frequency. The amplitude error was obtained by comparing the calibrated amplitude to the 
test resistor (Rcal) nominal value. The residual phase was considered to be the phase error, 
since it was expected to be 0°. 
The results on table 15 show that all the errors are lower than the unit. They might 
not reflect well the errors associated to the calibration process since the calibration 
parameters were applied to the calibration of the same resistor in which they were acquired. 
There was not a distinguished variation of the error with the test resistor or with the 
frequency.  
 
Table 15) Absolute errors from the evaluation of the calibration parameters on test data from the same resistors: 
Average values from all the resistances at the same frequency. 
Mean absolute errors 
Frequency (kHz) Amplitude (Ω) Phase (°) 
50 0.032 0.008 
70 0.017 0.077 
100 0.013 0.003 
Maximum 0.032 0.077 
 
The test with the RRC circuit (table 16) gives a better evaluation of the calibration 
performance for values near the range of interest for the ICG, especially important because its 
amplitude impedance is located in the non-linear region. The calibration parameters were 
obtained from a resistance of 24.8 Ω. The errors indicated are relative to the expected values 
(table 14). The nominal values are also presented as reference. These results are proof that the 
algorithm can deal with complex impedances for which it was not programmed. The errors are 
higher than those evaluated for the test resistors but are still lower than the unit. No 
conclusions can be derived in what comes to the variation of the error with the frequency. 
 
Table 16) Average impedance values measured on the RRC test circuit obtained with a calibration resistance of 
24.8 Ω and relative absolute errors (Δ).  
Frequency 
(kHz) 
Amplitude (Ω) Phase (°) Resistance (Ω) Reactance (Ω) 
Mean Δ Mean Δ Mean Δ Mean Δ 
50 24.019 0.568 -16.689 0.385 23.007 0.590 -6.898 0.011 
70 21.904 0.099 -13.904 0.122 21.262 0.107 -5.263 0.021 
100 21.138 0.372 -10.856 0.171 20.760 0.355 -3.981 0.130 
Maximum - 0.568 - 0.385 - 0.590 - 0.130 
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The impracticability of the original calibration procedure is noticeable even in the 
evaluation of the errors introduced, since the calibration resistance has to be chosen in 
accordance to the expected impedance value which will introduce different errors in the 
measurement of the same impedance in accordance to the operator judgment. Testing all the 
combinations of Rcal/RRC or Rcal/R was not made since it has little practical significance. 
 
The original calibration procedure of the AD5933 relies on the Rcal nominal value 
(taken as amplitude rather than a real impedance component) to determine the calibration 
parameters and the non-calibrated amplitude returned by the system presents a direct 
relation to such value. This way the variation of the calibration parameters with the non-
calibrated amplitude was studied, as the most relatable value to the load amplitude in general. 
 
Amplitude gain factor and system phase as a function of the non-calibrated amplitude  
  
 
Figure 46) Variation of amplitude gain factor (left) and system phase (right) with the non-calibrated amplitude 
value. 
 
The amplitude gain factor presents a non-linear variation with the raw amplitude 
value (figure 46). The non-linearity is particularly evident for low resistance values, showing a 
curvature similar to the one verified for the current across the load calculated from the 
AD8220 voltage output (figure 44), which is probably an important contribution to this 
observation. Nevertheless, the overall percent variation of the gain factor with the amplitude 
is small, presenting values of 3.41%, 5.18% and 4.92% at 50, 70 and 100 kHz, respectively. The 
system phase presents a relation to the raw amplitude value similar to that presented for the 
test resistance nominal value. The percentage variation of this value is 2.2%, 2.81%, and 3.58% 
at 50, 70 and 100 kHz. In both cases the correction parameters have a significant variation with 
frequency. 
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After these preliminary studies the calibration data was used to establish a 
mathematical model to estimate the calibration parameters based on the raw amplitude of the 
load, a descriptor of the load that can be directly accessed during the acquisitions providing 
information about its value.  The mathematical tool Eureqa [84] was employed to perform the 
data fitting and determine six mathematical expressions to describe each of the calibration 
parameters as a function of the raw amplitude (figure 46), at the three working frequencies (to 
confer the fitting plots refer to Appendix E).  
The model was tested using data from the test resistors and the RRC. For each 
component tested the calibration parameters were deduced based on the average raw-
amplitude of each acquisition on that component by applying the correspondent expressions. 
 
Table 17) Absolute errors from the evaluation of the calibration model on the test resistors: average values from 
all the resistances at the same frequency. 
Frequency 
(kHz) 
Mean absolute errors 
Amplitude (Ω) Phase (°) 
50 0.225 0.041 
70 0.176 0.054 
100 0.166 0.070 
Maximum 0.225 0.070 
 
The mean absolute error (table 17) on the amplitude for the calibration procedure 
using the mathematical models is higher than before (table 15), but the phase error is lower. 
This data is very optimistic, but in relative terms can show a good performance of the 
calibration model, since both errors are still lower than the unit, not showing a significant 
variation over the first evaluation. 
 
Table 18) Average impedance values from the RRC test circuit obtained from calibration parameters based on the 
calibration algorithm models and relative absolute errors (Δ). 
Frequency 
(kHz) 
Amplitude (Ω) Phase (°) Resistance (Ω) Reactance (Ω) 
Mean Δ Mean Δ Mean Δ Mean Δ 
50 23.911 0.460 -16.654 0.420 22.908 0.491 -6.853 0.034 
70 21.942 0.137 -13.827 0.199 21.306 0.151 -5.244 0.040 
100 21.066 0.300 -11.028 0.342 20.677 0.271 -4.030 0.179 
Maximum - 0.460 - 0.420 - 0.491 - 0.179 
 
For the RRC evaluation (table 18), the amplitude errors decreased and the phase 
error increased in comparison to the first evaluation (table 16), but all error values are below 
the unit, showing accordance between expected and calculated impedance values. 
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The evaluated errors although presenting small absolute values are still higher than 
the expected amplitude for the cardiac impedance signal (Appendix A). This is although a 
limitation of the technic that relies on a small amplitude signal to obtain its conclusions.  
 
5.3.1. Automated calibration procedure 
Based on these models was established an automated calibration procedure for the 
GUI (section 4.3), executed automatically at the beginning of each acquisition. Taking into 
account the final application of this system, a 10 s evaluation period was established in the 
beginning of each measurement to estimate the average raw amplitude used to calculate the 
calibration parameters for that measurement. The waiting time is not ideal, since it is too long 
for practical implementation, but is the minimum time necessary to account for the impedance 
variations due to the respiratory processes, that cause the most significant baseline variation 
of the thoracic impedance. It was estimated that during an acquisition the average raw 
amplitude based on the 10 s period represents the average value from the whole acquisition 
with an error of 2 %.  
The effect of using a single pair of calibration values to correct a varying impedance 
as well as the variation introduced on the calibrated data by the 2% deviation on the raw 
amplitude were studied using true thoracic impedance data (Appendix F). The maximum 
discrepancy from the reference value - calibrated with parameters from the models using the 
raw amplitude value averaged from the whole set of data – introduced by such variables was 
an order of magnitude inferior to the maximum error value already established based on the 
RRC evaluation. This way such influences were considered to be of less relevance. 
 
5.3.2. System measurement limits and errors 
The upper measurement limit of the system was tested on board using several 
resistors connected to the electrode plugs to determine when the AD5933 would saturate and 
based on those values the range of test resistors (table 12) was defined. The measurement 
limit is defined by the AD5933 rather than the VCCS that did not show any sign of saturation 
during the evaluation on resistors, as verified from the tests in the section 5.2, neither for the 
evaluation on a real acquisition setup. Since the limit is defined for the resistors at the 
instrumentation amplifier terminals, the stray capacitances from the interface with the patient 
were not considered. In such case the interval would be narrower so that the VCCS output load 
would still be lower than 2.39 kΩ (section 5.1), although this does not have practical relevance 
since the thoracic impedance range is much below that limit. 
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The lower limit of measurement was defined by the lowest value tested and 
considering that the system was calibrated to deal with it. A remark as to be made towards 
this value since the SNR is not ideal at the AD8220 output for such small impedance.  
 
Table 19) Summary of system capabilities. 
Parameter Range 
Frequency 50 kHz, 70 kHz or 100 kHz 
Impedance amplitude 10 to 865 Ω 
Impedance phase 0 - 2π rad 
Mean absolute amplitude error 0.46 Ω 
Mean absolute phase error 0.42 ° 
 
The summary of the system capabilities is presented on table 19. The errors specified 
are based on the highest known uncertainty: the one evaluated using the RRC circuit. 
Statistically this might not be correct, but the error evaluation for the maximum gives a better 
approximation to the overall error associated with the approximated calculations and the 
system limitations. The error analysis performed on measurements directly obtained from the 
system was based on those values (δ|Z| and δθ). For the resistance and reactance an error 
propagation (equations 35 and 36) is considered, based on their calculation from the 
amplitude and phase (equations 29 and 30). 
 
𝛿𝑅𝑙𝑜𝑎𝑑 = √(𝑐𝑜𝑠𝜃 × 𝛿|𝑍|)2 + (|𝑍|𝑠𝑖𝑛𝜃 × 𝛿𝜃)2 
( 35 ) 
 
 
𝛿𝑋𝑙𝑜𝑎𝑑 = √(𝑠𝑖𝑛𝜃 × 𝛿|𝑍|)2 + (|𝑍|𝑐𝑜𝑠𝜃 × 𝛿𝜃)2   
( 36 ) 
 
 
5.4. ECG time delay 
Analog filtering introduces delays on the signal output. Since the ECG and ICG 
measurements need to be synchronized, the time delay introduced on the ECG signal by the 
filtering components on the circuit was studied in order to correct it. In this evaluation the 
system was considered linear phase, i.e. the filter introduces a constant delay for all the signal 
frequencies and no frequency distortion. This is not true and is easily verified from the ECG 
signal augmented waves, but is still a good approximation once the objective is only to 
dislocate the wave in terms of an absolute time delay and not correct any frequency non-
linearity otherwise introduced by the commercial system.  
The filtering components on figure 47, between the test points, are considered to 
introduce delay, since they are directly in the signal path (to assess the complete circuit 
schematic please refer to Appendix C). The amplifier delay was not studied under the 
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assumption that its contribution would not be relevant in comparison with the other 
components. 
 
Figure 47) ECG front-end block diagram [82]: only components that are considered to introduce delay are 
identified. The delay evaluation was made in the identified test points. 
 
The output of the first differential stage (T1) shown to be too noisy and flat to allow 
its comparison to the front-end output (T3), for that reason the delay was roughly estimated in 
a two-step process. The active low pass filter (T1-T2) was simulated with the Orcad® circuit 
simulation tool. The input to the low pass filter was a sinusoid with amplitude of 0.01 V and 
frequency 1 Hz, very close to the heart rate and, in short, the lowest frequency of interest 
(figure 48). The result of this evaluation was a delay of 4.53 ms, based on the difference 
between the zero crossing points of the input and output waves. 
 
 
 
 
 
Figure 48) Low pass filter circuit simulated using Orcad® (left) and graphical representation of the input and 
output voltage over 1 s (right). The blue circle indicates the zero crossings where the delay was evaluated. 
 
The notch filter input was perceptible (T2), allowing its direct comparison with the 
ECG front-end output (T3) in order to access the delay. The signals where simultaneously 
acquired at the notch filter input and at the front-end output with the Picoscope® interface 
(figure 49). The cross correlation of those signals was performed over 5 acquisition samples 
with 5 seconds each, using Matlab®. The result was an average delay of 5.50 ms with a 
standard error of the mean of 0.17 ms. The delay variation between data samples, reflects the 
non-linear frequency response of the filter for a variable signal, still the variation is not 
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significant when compared to the overall value, being contained in the minimum sampling 
period (2.5 ms). 
 
 
Figure 49) Normalized notch filter input signal and ECG front-end output. The lack of synchronization between 
the ECG peaks in both signal is visible despite the noise (related to the antenna effect from the direct 
measurement). 
 
Considering only the circuit parts studied, the overall delay introduced is 10.03 ms. 
The ICG and ECG where synchronized, at the end of each acquisition, by software taking into 
account this value. 
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The ultimate goal of the developed ICG system is to acquire the thoracic 
impedance and ECG signals simultaneously on a human subject in order to assess the 
possible hemodynamic parameters. To verify the system performance on actual ICG 
measurements a pilot study was conducted on a small number of volunteers.  
The acquisition procedure, the signal analysis – pre-processing, ECG-QRS 
detection, ensemble averaging and feature extraction - and the results related to relevant 
physiological parameters are presented and discussed in the following chapter. 
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6.1. Methodology 
The ICG acquisition proceeding as well as the signal processing and analysis 
performed over the thoracic impedance and ECG signals in order to obtain the possible 
hemodynamic parameters are described over the next sections. At this point, should be 
clarified that no automated algorithms were developed in order to process the ICG signal. 
 
 Data Acquisition protocol 
The data collection was performed on three healthy subjects (please report to table 
21, page 88) with the objective of testing the effectiveness of the developed system. For every 
subject two variables were tested: the ICG electrode configuration and the excitation current 
frequency (50 kHz and 100 kHz). The objective of using two configurations is to find the most 
appropriated for this system in terms of practicality, SNR and general results. 
The measurements were all performed with the subjects sitting upright for 
simplification of the acquisition set-up. The heart rate was measured with a cuff monitor and 
registered at the beginning of the acquisition procedure. Before the electrodes application, the 
skin was prepared with an ECG conductor spray.  
The 3 lead ECG was performed simultaneously to the ICG and the electrodes where 
placed in accordance to the system specifications - right arm, left arm and the ground on the 
right leg, above the ankle (section 4.1.3). 
Two ICG electrode configurations were tested: the first according to Qu et al. [28] – 
anteroposterior configuration described on section 2.5.1.1 - and the second as proposed by 
Penney et al. [85] – posterolateral configuration described on section 2.5.1.2. As a matter of 
uniformity, the positive leads (considering the VCCS output the high current lead) for ICG 
where placed above the negatives throughout the acquisitions, as suggested on the web page 
of the impedance cardiography system from Biopac® [31]. For each electrode configuration the 
distance between the sensing electrodes was measured with a metric tape. An initial test was 
performed to verify if the electrode placement was correct. During that time the subjects were 
asked to perform a stressed inspiration-apnea-expiration period to verify the right variation of 
the baseline impedance – a rise in the impedance magnitude during inspiration (figure 13). 
Two acquisitions of 60 seconds were then performed at a sampling rate of 400 Hz for an 
excitation frequency of 50 kHz and repeated for 100 kHz. 
With different electrode configurations the distance between sensing electrodes 
could not be maintained. Since the electrodes are placed in accordance to physical markers 
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that vary from subject to subject, the distance between sensing electrodes for different 
subjects could not be maintained either, while using the same configuration. 
The ECG electrodes had to be relocated after the first test so that the signal would 
not saturate. In all situations they were placed between the middle of the forearm and the 
middle of the arm. Due to this observation, ICG and ECG data was later separately collected 
using the same technics described above to verify the signals influence on each other. 
 
6.1.2. Signal-to-noise ratio 
The signal-to-noise ratio (SNR) of the impedance meter and ECG units was evaluated 
separately over calibrated non-filtered data from independent acquisitions, to eliminate any 
influence of the systems on each other. The SNR was calculated in accordance to equation 37.   
 
𝑆𝑁𝑅(𝑑𝐵) = 10 ×  𝑙𝑜𝑔10 (
𝑆𝑖𝑔𝑛𝑎𝑙 𝑃𝑜𝑤𝑒𝑟
𝑁𝑜𝑖𝑠𝑒 𝑃𝑜𝑤𝑒𝑟
) ( 37 ) 
 
The ICG signal power was obtained from the squared RMS amplitude of the raw 
signal with length (N). The baseline was included in this calculation since it presents relevant 
information. The noise associated with this signal was obtained from the same signal by 
applying a stop-band filter to the signal frequencies, since it could not be directly obtained 
from the system because the instrumentation amplifier would saturate the AD5933 entry 
when no load was at its terminals, by moving the DC reference level to higher values. 
 
𝑆𝑖𝑔𝑛𝑎𝑙 𝑃𝑜𝑤𝑒𝑟𝐼𝐶𝐺 =
(√∑ 𝑅𝑎𝑤 𝐼𝑚𝑝𝑒𝑑𝑎𝑛𝑐𝑒 𝑆𝑖𝑔𝑛𝑎𝑙 2(𝑖)𝑁𝑖=1 )
2
𝑁
 
( 38 ) 
 
Similarly, the ECG signal power was evaluated in accordance to equation 39 using the 
non-filtered signal and removing the baseline level. The noise component was obtained from a 
measurement with the electrodes disconnected from the subject. 
 
𝑆𝑖𝑔𝑛𝑎𝑙 𝑃𝑜𝑤𝑒𝑟𝐸𝐶𝐺 =
(√∑ (𝑅𝑎𝑤 𝐸𝐶𝐺 𝑆𝑖𝑔𝑛𝑎𝑙(𝑖) − 𝐷𝐶 𝑙𝑒𝑣𝑒𝑙(𝑖)) 2𝑁𝑖=1 )
2
𝑁
 
( 39 ) 
 
In both cases the noise power was evaluated in accordance to equation 40 by 
removing the baseline introduced by the system. 
 
𝑁𝑜𝑖𝑠𝑒 𝑃𝑜𝑤𝑒𝑟 =
(√∑ (𝑁𝑜𝑖𝑠𝑒(𝑖) − 𝐷𝐶 𝑙𝑒𝑣𝑒𝑙(𝑖)) 2𝑁𝑖=1 )
2
𝑁
 
( 40 ) 
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6.1.3.  Signal pre-processing  
Several artifacts of physiological and non-physiological origin affect both thoracic 
impedance (section 2.7) and ECG signals. Either suffer interferences from patient movement 
(motion artifact, 0.1-10 Hz), respiration (baseline wander, 0.04-2 Hz), muscle contraction 
(electromiographic interference, 6-500 Hz [86]), bad coupling of the electrodes to the patient 
(contact noise), as well as the power-line interference with a characteristic frequency of 50 Hz 
and other electromagnetic interferences from the equipment [12].  The components of 
interest for the ICG analysis are between 0.8-20 Hz [50], the respiratory impedance relevant 
information is between 0.05-0.5Hz [54] and the ECG relevant information is commonly 
assumed to reside in the 0.5-40 Hz band [87].  
The signal filtering applied in this case presents steeper frequency cuts in order to 
suit the actual system needs. This allowed the baseline stabilization and elimination of the 
spurious fluctuations at higher frequencies, without degrading the general shape of the 
signals. The calibrated and synchronized impedance and ECG signals were band-pass filtered in 
the frequency domain in the pass bands indicated on figure 50. 
 
 
Figure 50) Pre-processing. 
 
Commonly the thoracic impedance signal (Z(t)) is subtracted from the mean value 
(Z0) and low pass filtered to remove higher frequency interferences, the first derivative (ICG) of 
such signal (ΔZ) relies on the ensemble averaging of the signal or other filtering technic to 
eliminate the respiratory component [50]. In the present case, the noisy thoracic impedance 
signal was directly filtered around the cardiac frequency using a strong band-pass filter, 
Z0 ECGΔZrΔZc
ICG
Raw ECGRaw thoracic Impedance
Average BP Filter
1
st
derivative
BP Filter
Time (s) Time (s)
×-1
BP Filter
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directly eliminating the most relevant interferences, and only after that the first derivative of 
the inverted signal was performed to avoid noise amplification. 
The ICG was calculated based on both the impedance amplitude and the real 
components in order to overcome the lack of information about which of the impedance 
components is studied. The base impedance (Z0) was obtained from the mean value of each of 
those impedance components. The other thoracic impedance components - phase and 
reactance - show no relevance for the ICG analysis related to the cardiac activity, this way they 
were only evaluated in terms of their average values to verify their accordance to the 
information in the literature and even though they were filtered alongside with the amplitude 
and resistance no further analysis was conducted for the lack of reference values to be 
compared with. 
The component related to the respiratory impedance was also separated from the 
original thoracic impedance signal to verify the variation of its influence with the electrode 
configuration.  
 
The offline pre-processing procedure implemented in the software interface (section 
4.3) includes the basic filtering described for the thoracic impedance components and the ECG, 
and goes as far as the ICG calculation, implementing all the steps on figure 50.  
 
6.1.4. QRS detection 
The automatic detection of the QRS complex on the ECG signal is an important step 
in the current system. The ICG signal correct processing relies on a good detection 
performance of the R wave.  
The QRS detection algorithm employed was based on the traditional Pan and 
Tompkins algorithm [88], presenting a simple solution and yet a good performance [89]. The 
algorithm consists on applying several filters to the ECG signal in the time domain in order to 
obtain a square wave for each QRS complex, evaluated in respect to a threshold to perform 
the peak detection. The fundamental modifications to the original algorithm are related to the 
initial band-pass filter in the frequency domain instead of the finite impulse response filter 
applied in the time domain; the repeated squaring of the signal (raised to 4) instead of a 
simple squaring, in order to better differentiate the R wave from the T wave, that would 
sometimes show an amplitude near the first; and the simplified peak detection based on the 
relation to a non-adaptive threshold. 
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The squared wave is compared to the threshold - a fraction of the maximum ECG 
amplitude – identifying the relevant peaks. The R point is the maximum of the original signal 
inside each relevant segment identified, the Q point is the minimum before that maximum and 
the S point is the minimum after the maximum.  
 
 
Figure 51) QRS detection algorithm steps (based on the Pan and Tompkins algorithm). Band-pass filtering: 
removes interferences; Derivative filtering: enhances peaks; SquaringxSquaring: turns the signal positive and 
reinforces the peaks in a non-linear way; Moving window integration: merges nearby peaks. 
 
The average specificity and sensitivity of the algorithm for each characteristic point 
was determined by analyzing the results on three signals acquired on different subjects with 
the current system with simultaneous ICG acquisition – worst case. The evaluation was 
performed in accordance to equations 41 and 42, considering that: true positive is a correctly 
detected point; false positive is a falsely detected beat; false negative is an undetected beat 
and true negative corresponds to the points well detected different from the one being 
evaluated. This showed an acceptable performance for the R wave (table 20). 
 
 
Band pass filtering
Derivative filtering
Squaring x Squaring
Moving window integration
ECG raw input signal
QRS output
Time (s)
Time (s)
Pre-processing
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Table 20) QRS detection algorithm’s performance. 
Feature # beats Sensitivity (%) Specificity (%) 
Q 
242 
89 91 
R 99 93 
S 92 92 
 
 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
 
( 41 ) 
 
 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
 
( 42 ) 
 
 
6.1.5. Wave segmentation and Ensemble average 
The ICG signal was segmented in order to perform its ensemble average over 
periodic repetitions, synchronized by the R peak from the ECG signal (figure 52). This process 
eliminates the beat-to-beat variability but reduces the effect of spurious components on the 
signal resulting on a final unique wave that can be analyzed to extract the relevant features. 
The ensemble averaging was performed over the minimum RR period by summing the 
digitized samples gated by the R wave and dividing the result by the number of beats (N) 
considered in the analyzed period [42]. The segmented beats were analyzed one-by-one, to 
exclude those that were badly segmented thanks to erroneous R peak identification, as well as 
the beats that presented affected ICG waves. The ΔZ and ECG waves were also averaged to be 
kept as a reference. 
 
Figure 52) Ensemble average: ICG beats segmented by the R-ECG peak and averaged ΔZ, ICG and ECG signals over 
N beats. 
 
At this point the base thoracic impedance (Z0) was re-evaluated (Z0’), taking into 
account only the thoracic impedance data correspondent to the accepted ICG segments. 
Ensemble Average
ICG segments
Incorrect segmentation Unstable signal
ΔZ ICG ECG
Averaging time (s)
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6.1.6.  Feature extraction 
The signal quality did not allowed the identification of all the characteristic points on 
the ICG averaged curve, for that reason only the fundamental B, C and X points were studied. 
Those features were manually marked on a panel similar to the one presented on figure 53, 
using Matlab® tools. 
 
 
Figure 53) Feature extraction panel with relevant points on the ICG averaged signal. The ΔZ and ECG, normalized 
to the ICG maximum amplitude, were only used as references to correctly identify the characteristic points. 
 
The highest ICG peak after the R wave from ECG was taken as the C point [90]. The B 
point was assumed to be at the zero-crossing point of the ICG curve prior to the point C [91] . 
This presented the most straightforward identification method, although some signals 
presented the inflection before C above zero and in those cases the minimum before C was 
considered as the B point [90]. The X point corresponds to the time instant where the lowest 
ICG value occurs during the negative section to the right of C (section 2.7.1). 
 
6.1.7.  Assessment of Hemodynamic Parameters 
Based on the information extracted during the signal analysis the heart rate (HR), the 
systolic times (PEP and LVET) and the cardiac volumes (SV and CO) were obtained.  
Relative to the assessment of relevant parameters from the signal analysis some 
explanations are required: 
B
C
X
ΔZ
ICG
ECG
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 The (dz/dt)max is the maximal amplitude from the baseline to the peak of the ICG curve 
[4], corresponding to the C abscissa (figure 53). 
 For the correct evaluation of PEP some authors consider the use of the Q-wave onset 
mandatory [92], others are that consider the Q peak a better solution [93]. In the present case 
the Q onset was used. To overcome the difficult Q onset identification was applied a method 
that seems to be current practice to estimate such value, by subtracting a fixed value of 48 ms 
from the time of the R wave peak. This method presents a relevant abstraction resulting on an 
estimation only [93, 92]. 
 The LVET being the time interval between B and X, was directly evaluated from the 
abscissa difference of those points. 
 The HR was calculated from the average RR interval evaluated from the QRS detection 
algorithm output. The results had to be corrected by visual evaluation when the algorithm 
performed poorly. 
 The SV was calculated from the Kubicek’s formula, using a constant blood resistivity 
value. The value of 147 Ω.cm was assumed for the purpose of this work, following the 
reference on the Biopac® cardiac output system’s manual [94]. 
A resume from all the relevant parameters collected during the signal analysis and 
the uncertainties associated with such values, used in their evaluation process, is presented on 
Appendix G. 
 
6.2. Results and discussion 
The hemodynamic parameters vary with the position of the subject [37]. The 
standard position for ICG measurements is the supine, but several studies have been 
conducted while sitting or standing, showing a postural influence on the hemodynamic 
parameters obtained. The base thoracic impedance increases and the (dz/dt)max value 
decreases from supine to sitting, resulting on a reduction of SV [95]. The time intervals are also 
affected as the heart rate increases with the body straightening [96]. Although, the absolute 
values reported from evaluations on different systems while sitting [97, 98] show, in 
comparison to the reference intervals for such values, higher SV, higher PEP and LVET inside 
the interval (Appendix B). The absolute values that could be assessed help to corroborate the 
values obtained from this system, since no direct comparison between the reference position 
and the sitting position was available.  
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During the acquisition procedure a crosstalk between the impedance and the ECG 
units was detected, that punctually led the ECG signal to saturation. For that reason, a 
posterior study was performed to compare the results from independent and simultaneous 
acquisitions of the two signals in order to establish a suitable error margin to the signal 
analysis. Following this, the results from thoracic impedance measurements alone will be first 
presented as a reference. The data obtained from simultaneous acquisitions of impedance and 
ECG on three subjects (table 21) and the physiological parameters determined by the 
subsequent signal analysis will then be presented and discussed under the light of the system’s 
crosstalk influence.  
 
Table 21) Subject data summary. The heart rate values presented are only indicative values, since they were not 
monitored throughout the long acquisition periods. 
# Gender (F/M) Age (years) Weight (kg) Height (m) Heart rate (bpm) 
1 F 23 50 1.6 78 
2 M 24 68 1.68 55 
3 F 22 54 1.65 87 
 
It should be stressed that the small population under study does not permit a 
relevant statistical analysis. Many factors can affect the impedance measurements which can 
lead to erroneous conclusions when analyzing such a limited amount of data, this way the 
results were only analyzed in average terms to verify the general accordance to the reference 
values in the literature. 
The error analysis is made in accordance to the established on Appendix G, unless 
otherwise noticed. The comparison to reference values implies the values on Appendices A 
and B. 
 
6.2.1. Signal-to-Noise Ratio 
In accordance to the procedure described on section 6.1.2, the average SNR was 
evaluated using two sets of impedance and ECG data acquired independently from subject #3. 
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ECG: signal and noise 
 
 
Figure 54) ECG signal without pre-processing and noise level obtained with the electrodes unplugged. The DC-
level is not relevant in either case. The signal was acquired on subject #3 at a sampling frequency of 400 Hz. 
 
The visual comparison of the ECG’s signal and noise (figure 54) shows a relevant 
amplitude difference. 
 
ECG: FFT power spectrum 
 
Figure 55) ECG signal’s power spectrum in dB, after removing the irrelevant baseline. 
 
The FFT (figure 55) shows a particularly noticeable peak at 50 Hz, relative to the 
power line noise. This indicates that the front-end notch filter is not very effective. The signal 
power at low frequencies, where the relevant ECG components are, is higher. 
 
Table 22) ECG system's SNR. The presented value results from averaging the results of two acquisitions. 
SNR (dB) 
27.9 
 
The ECG’s SNR value (table 22) is general terms acceptable, permitting the noticeable 
distinction between signal and noise. 
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Impedance: signal and noise 
 
 
Figure 56) Impedance signal without pre-processing and noise level obtained by applying a stop-band filter to the 
signal frequencies. The DC level is relevant in the impedance case. The signal was acquired at a sampling 
frequency of 400 Hz, using the anteroposterior configuration, without the ECG parallel acquisition, while applying 
an excitatory AC current with a frequency of 50 kHz on subject #3. 
 
The identified noise includes some physiological components not accounted in the 
process, for that reason it presents some periodicity similar to the cardiac impedance 
component. The amplitude relation between noise and signal is an intrinsic limitation from the 
ICG technic, which presents small varying amplitude when compared to the baseline value, 
resulting on similar amplitude of noise and signal, although with different frequencies. 
 
Impedance: FFT power spectrum 
 
Figure 57) Impedance signal’s power spectrum in dB. 
 
The FFT (figure 57) shows noisy components throughout the spectrum, with an 
increased component around the origin, and the DC level correspondent to the baseline at 0 
Hz. 
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Table 23) Impedance system's SNR. The presented values result in each case from averaging the values of two 
acquisitions. 
Electrode configuration F (kHz) 
SNR (dB) 
Specified Mean 
Anteroposterior 50 50.58 
51.44 
 100 51.73 
Posterolateral 50 51.73 
52.45 
 100 52.69 
 
The SNR value from the impedance system is higher at higher excitation frequencies 
and in average is higher for the posterolateral configuration. The SNR presents an acceptable 
value, since the mean value is a relevant part of the signal. 
 
6.2.2.  Thoracic impedance signal  
The thoracic impedance signal components were evaluated in terms of their average 
values and the cardiac and respiratory components were explored in terms of their amplitude 
and resistance variation in order to verify its accordance to the reference values and verify 
which configuration would suffer less from the breathing modulation, respectively.  
The impedance signals presented in this section were acquired on subject #3 
following the same acquisition procedure on the methods section. Although extra acquisitions 
were performed with the ECG electrodes unplugged, after every simultaneous acquisition to 
maintain the same exact ICG electrode configuration and proportionate the reference thoracic 
impedance signal that is presented here. 
 
Table 24) Thoracic impedance average (Z0) values from the calibrated curves obtained from two acquisitions at 
each frequency. 
Electrode 
configuration 
F 
(kHz) 
L (cm) |Z0| (Ω) Ɵ0 (°) RZ0 (Ω) XZ0 (Ω) 
Anteroposterior 
50 
26 ± 1 
22.90 ± 0.46 -6.04 ± 0.42 22.77 ± 0.46 -2.41 ± 0.17 
100 22.16 ± 0.46 -9.40 ± 0.42 21.86 ± 0.45 -3.62 ± 0.18 
Average - - 22.53 ± 0.26 -7.72 ± 1.19 22.32 ± 0.32 -3.01 ± 0.43 
Posterolateral 
50 
36 ± 1 
27.33 ± 0.46 -5.04 ± 0.42 27.23 ± 0.46 -2.40 ± 0.20 
100 26.18 ± 0.46 -5.38 ± 0.42 26.06 ± 0.46 -2.46 ± 0.20 
Average - - 26.76 ± 0.41 -5.21 ± 0.12 26.64 ± 0.41 -2.43 ± 0.02 
 
According to the results on table 24, the average magnitude and resistance are 
always inside the reference interval (15-45 Ω). The absolute value of the averaged phase angle 
is below the expected values for the posterolateral configuration (6.4-10.92 °), but fairly close. 
The difference between the amplitude and real impedance components is also 
contained in the error interval, indicating that the use of one or another in the calculation will 
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not show an important difference. The thoracic reactance compared to the resistance value is 
small (11%, and 9% for the anteroposterior and posterolateral configuration, respectively), and 
as foreseen can be ignored. Since the human body only presents capacitive components the 
reactance presents a negative signal. 
As expected, the impedance amplitude and real component both decrease with the 
frequency of the excitation ac-current, presenting though a very small variation across 
frequencies, contained in the error interval. Although, the phase angle relative to the positive 
x-axis decreases, causing the absolute value of the imaginary component to increase, resulting 
on a higher absolute reactance at higher frequency. The added component in the imaginary 
part of the impedance is probably due to a leakage current that adds the impedance of the 
sensing electrodes to the impedance of the chest, which the calibration process could not 
avoid, introducing an unbalanced correction. The increased error in the reactive part of the 
impedance seems to be a common problem and is usually attributed to stray capacitances [20, 
17]. 
Both configurations show in general similar results in the relevant parameters, with 
the posterolateral configuration presenting higher impedance amplitude related to the 
increased distance between the sensing electrodes.  
 
The cardiac impedance signal, obtained from filtering the thoracic impedance 
amplitude and real component, and its first derivative were evaluated in terms of their peak 
values using an algorithm for peak-detection on Matlab®. The graphical presentation of the 
cardiac impedance signal (figure 58) based on amplitude and resistance presented no visual 
difference, for such reason and to avoid redundancy only the waves derived from the 
amplitude evaluation are shown. 
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 Cardiac impedance component 
            50 kHz         100 kHz 
 Anteroposterior configuration 
 
 
 
 
 Posterolateral configuration 
 
  
Figure 58) Cardiac impedance de-noised signals: impedance (ΔZc) and ICG (dZc/dt). 
 
The signals produced by the anteroposterior configuration seem more stable at 50 
kHz. The opposite is verified for the posterolateral configuration, although in this case the 
impedance signal at both frequencies produced ICG signals with less fidelity. The ICG signals 
present in either cases, low resolution, with relatively distinctive B and Y notches, while the 
other points are almost unidentifiable thanks  to several inflections around their expected 
location. 
The literature suggests that the cardiac activity is better recognized at lower 
frequencies, [20], which in part relates to these results. 
 
Table 25) Peak-to-peak values of the de-noised cardiac impedance component (ΔZc) obtained from the thoracic 
impedance curves. The uncertainties were estimated using the standard error of the mean. 
Electrode configuration F (kHz) Δ|Zc|(Ω) ΔRZc (Ω) 
Anteroposterior 
50 0.20 ± 0.01 0.19 ± 0.01 
100 0.23 ± 0.02 0.23 ± 0.02 
Average - 0.21 ± 0.01 0.21 ± 0.01 
% of the base value - 0.95 0.95 
Posterolateral 
50 0.17 ± 0.01 0.17 ± 0.01 
100 0.19 ± 0.01 0.19 ± 0.01 
Average - 0.18 ± 0.01 0.18 ± 0.01 
% of the base value - 0.68 0.67 
 
The variations in the base impedance related to the cardiac activity (table 25) are 
inside the range of accepted values (0.04-0.4 Ω, amplitude) for both configurations. The peak-
to-peak values show in both cases an increase with frequency, although it is contained in the 
Time(s) Time(s) 
Time(s) Time(s) 
Chapter 6: Validation Tests 
94 
 
error interval. The anteroposterior configuration presents more pronounced variations but the 
difference is not very significant. 
It should be noticed that the absolute variations of the impedance components are 
smaller than the absolute error attributed to the system’s measurement capability. This is a 
limitation intrinsic to the technic and one way to overcome this situation is by making several 
acquisitions and averaging the results. In the present case more than performing several 
acquisitions, performing them at different frequencies with different electrode configurations 
and verifying in general coherent results is enough to confer the reliability needed to this 
study. 
 
Table 26) Maximum peak value of the first derivative of the cardiac impedance component (ICG). The 
uncertainties were estimated using the standard error of the mean. 
Electrode configuration F (kHz) 
(dZ/dt)max (Ω/s) 
|Z| R 
Anteroposterior 
50 1.96 ± 0.18 1.94 ± 0.18 
100 2.70 ± 0.16 2.62 ± 0.16 
Average - 2.33 ± 0.26 2.28 ± 0.24 
Posterolateral 
50 1.66 ± 0.22 1.65 ± 0.22 
100 2.15 ± 0.20 2.10 ± 0.20 
Average - 1.90 ± 0.17 1.88 ± 0.15 
 
The maximum value of the first derivative of the cardiac impedance signals (table 26) 
is in average contained within the reference interval of normality (0.8-2.5 Ω/s). The expected 
effect of a narrow filtering band would be the decrease of the (dz/dt)max value [51], which does 
not seem to happen since all the values are near the top of the reference interval. Also, the 
sitting posture would lead to the same observation. The contrary observation might be related 
to a real physiological particularity of the subject. There is a noticeable variation of (dz/dt)max, 
across frequencies showing increased values at 100 kHz and also across configurations with 
the anterolateral configuration presenting increased values. 
 
The respiratory impedance signal, obtained from filtering the thoracic impedance 
amplitude and real component at lower frequencies, was also evaluated in terms of its peak 
values. Once more the amplitude is the only impedance component present since the signals 
present the same shape and overall magnitude.  
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Respiratory impedance component 
           50 kHz         100 kHz 
Anteroposterior configuration 
 
 
 
Posterolateral configuration 
  
 
Figure 59) Respiratory impedance amplitude. 
 
The resistance increases during inspiration [20], which was manifestly verified during 
the initial tests before the acquisitions (not presented), and shows a clean sinusoidal variation 
during the respiratory cycle.  
 
Table 27) Peak-to-peak values of the de-noised respiratory impedance component (ΔZr) obtained from the 
thoracic impedance curves. The uncertainties were estimated using the standard error of the mean. 
Electrode configuration F (kHz) Δ|Zr|(Ω) ΔRZr (Ω) 
Anteroposterior 
50 0.08 ± 0.01 0.09 ± 0.01 
100 0.16 ± 0.04 0.17 ± 0.04 
Average - 0.12 ± 0.03 0.13 ± 0.03 
% of the base value - 0.54 0.58 
Posterolateral 
50 0.21 ± 0.02 0.22 ± 0.02 
100 0.25 ± 0.03 0.25 ± 0.03 
Average - 0.23 ± 0.01 0.23 ± 0.01 
% of the base value - 0.86 0.88 
 
The respiratory component value (table 27) is far below from the expected values 
(0.675-2.025 Ω, amplitude), which only shows a weak influence of the respiratory signal on the 
signals recovered with the electrode configurations applied. The peak-to-peak value of the 
impedance is less than 1% of the base value and for the anteroposterior configuration this 
percentage is even lower than the cardiac component. The lower values are presented by the 
anteroposterior configuration at 50 kHz. 
The posture is known to affect the amplitude of the respiratory signal [54], but this 
factor was not taken into account in the comparison.  This way the conclusions established 
related to this component can vary while in supine. 
 
Time(s) Time(s) 
Time(s) Time(s) 
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From this analysis can be concluded that the values of interest for the ICG analysis 
present general accordance with the reference values. The signals returned by the 
anteroposterior configuration present better resolution for the ICG notches and seem to be 
more stable. Also this configuration is less affected by the respiratory modulation, which is 
easily justified by its sagittal electrode positioning. 
The distinction between amplitude and resistance at this level does not seem to 
introduce great differences in the impedance values relevant to the ICG analysis.  
 
6.2.2.1. ECG/ICG crosstalk influence 
The crosstalk was first detected when the ECG signal would saturate and re-appear 
after the ECG electrode re-positioning, showing sometimes an increased noise level. Latter, it 
was noticed that the removal of the ECG ground would cause a noticeable variation of the 
impedance baseline, while none of the other electrodes would have any effect. This is justified 
by the flow of current through the path of less resistance to the ground: the impedance meter 
ground presents the electrode-skin interface plus the grounded resistance in the path, while 
the ECG ground only presents the electrode-skin interface. 
Only the influence off the ECG on the impedance signal was studied, once the peak 
amplitude of the ECG signal is not relevant for the present study and the signal did not exhibit 
a noticeable distortion on the R peaks.  
Since this problem lacks from a correction at the hardware level, is not relevant at 
this point to comparatively analyze the influence of the crosstalk on every detail of the 
impedance wave. This way, the relevant values for the cardiac evaluation - Z0, (dz/dt)max – were 
compared in terms of their absolute difference in order to establish a suitable error margin for 
the results of the simultaneous acquisition based on the average difference of those values.  
The posterolateral configuration was less affected in terms of the impedance 
baseline dislocation, but it suffered from a (dZ/dt)max alteration similar to the one verified on 
the other configuration. Also, the direction of the affectation was not equal for all the 
parameters on the two configurations. To simplify the error evaluation the mean absolute 
variation noticed is presented as the uncertainty value (table 28). 
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Table 28) Effect of the ECG/ICG crosstalk: mean absolute error and maximum error percentage introduced. The 
results were evaluated on the average of two acquisitions at each frequency for each configuration studied. 
 Δ|Z0| (Ω) ΔƟ0 (°) ΔRZ0 (Ω) ΔXZ0 (Ω) 
Δ(dZ/dt)max (Ω/s) 
|Z| R 
Mean abs. 1.38 1.88 1.43 0.66 0.44 0.43 
Max. (%) 11.72 41.78 12.18 35.09 46.69 45.05 
 
The original error introduced by the system was ignored in the following calculations 
since the effect of the crosstalk introduces a much higher uncertainty. 
 
6.2.3. Impedance Cardiography signals and hemodynamic 
parameters 
The comparative analysis of the averaged thoracic impedance components (Appendix 
H) did not show any relevant discrepancy in comparison with the analysis performed before, 
presenting the same inaccuracies. The only difference was the variation of phase and 
imaginary component with configuration, showing higher absolute values in the posterolateral 
configuration, reversing the first analysis. The comparative analysis between subjects was not 
conclusive since the variations are in most cases contained in the error interval. 
The hemodynamic parameters were estimated at each frequency for each individual 
and for each configuration on two separated ensemble average processes, corresponding to 
two data acquisitions, and then the results were averaged. The ensemble average was 
sometimes performed on less than 20 beats for the same subject thanks to the low signal 
quality, which might affect the accuracy of the resultant averaged signal. The difference 
between the resistance and amplitude evaluations also has an inaccuracy introduced by the 
operator analysis since the resistance and amplitude curves were evaluated separately in what 
comes to the feature extraction. For such reason, even though the curves were similar and 
based on the same beats the characteristic points might have suffered small aleatory 
dislocations. 
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           50 kHz         100 kHz 
Anteroposterior configuration 
  
  
Posterolateral configuration 
  
  
Figure 60) Impedance cardiography signals (cardiac impedance, ICG) and ECG. Results from both electrode 
configurations while applying an excitatory AC current with frequency of 50 and 100 kHz, respectively. 
 
The impedance signals (figure 60) show increased instability at higher excitation 
frequencies, as noted before, producing a much distorted ICG wave. The posterolateral 
configuration presents signals with more distinctive features than those acquired on the same 
subject and without the ECG influence. It would be expected that the signal under the ECG 
influence would degrade, the fact that the contrary happens might indicate that the initial 
results probably have been originated from punctual influences. Anyway, this reflects less 
stability from this configuration. The averaged signals (graphically presented on Appendix I) 
showed in general more instability at 100 kHz. 
 
In order to simplify the study, the results were averaged for the same electrode 
configuration, ignoring differences between subjects - not conclusive - and across excitation 
frequencies - although noticeable in the base values, should not affect the final hemodynamic 
parameters, introducing its most important effect in the signal stability, as already noticed. 
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Table 29) Average impedance values for the same electrode configuration, employed to calculate the 
hemodynamic parameters. The uncertainties are evaluated in terms of the standard error of the mean. 
Electrode 
configuration 
L (cm) 
N 
beats 
Z0’ (Ω) (dZ/dt)max (Ω/s) 
|Z| R |Z| R 
Anterolateral 23 ± 1 218 17.94 ± 0.94 17.86 ± 0.94 1.75 ± 0.19 1.73 ± 0.19 
Posterolateral 33 ± 1 192 27.21 ± 1.04 27.03 ± 1.03 1.74 ± 0.16 1.72 ± 0.16 
 
The average values of thoracic impedance and (dz/dt)max (table 29) are in accordance 
to the reference values (15-45 Ω and 0.8-2.5 Ω/s, respectively). The average base thoracic 
impedance is higher for the postolateral configuration as expected from the increased distance 
between the electrodes, but the (dz/dt)max is very close to those of the first configuration. 
Although the standard error of the mean shows accordance between the values, the 
uncertainties associated with the individual values of (dz/dt)max correspond in average to 27% 
of the absolute value. 
The difference between Z0 and Z0’ was never higher than 0.5 %, which validates the 
procedure of considering only the base thoracic impedance of the averaged beats. 
 
Table 30) Average hemodynamic parameters for the same electrode configuration. The uncertainties are 
evaluated in terms of the standard error of the mean. 
Electrode 
configuration 
HR 
(bpm) 
PEP (s) LVET (s) SV (ml/beat) CO (L/min) 
|Z| R |Z| R |Z| R |Z| R 
Anterolateral 78.09 ± 
3.06 
0.11 ± 
0.01 
0.11 ± 
0.01 
0.29 ± 
0.01 
0.29 ± 
0.01 
124.00 
± 5.56 
123.74 
± 5.51 
9.70 ± 
0.61 
9.68 ± 
0.61 
Posterolateral 81.93 ± 
3.45 
0.11 ± 
0.003 
0.11 ± 
0.003 
0.27 ± 
0.005 
0.27 ± 
0.005 
100.09 
± 4.16 
100.52 
± 4.03 
8.24 ± 
0.60 
8.28 ± 
0.59 
 
The HR (table 30) is in accordance to the physiologically acceptable values (60-100 
bpm). The individual variation from the initial direct HR measurement can be easily explained 
by assuming that during the long acquisition process this parameter naturally changed. The 
PEP value was sometimes higher than the reference values (0.05-0.12 s), but is always inside 
the interval of values while sitting (0.11-0.14 s), showing no variation with the electrode 
configuration. In average the value is acceptable. The LVET average value is inside the 
reference interval (0.25-0.35 s), as well as the individual values from each subject, presenting 
in average a lower value for the posterolateral configuration. The SV is above the reference 
values (60-100 mL), but is always inside the estimated interval for measurements while sitting 
(74.5-142.7 mL). The CO is also augmented in accordance to the reference (4-8 L/min), which is 
related to the SV value but also to the increased HR while sitting. The SV and CO values are 
closer to the expectable when using the posterolateral configuration. 
The uncertainties presented on table 30, show acceptable accordance between the 
averaged values. Although, the individual values present much higher uncertainties (to assess 
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the specified values refer to Appendix H), with maximum error percentages of 67% for PEP, 
32% for LVET, 45% for SV and 45% for CO. 
 
The conclusions from this analysis can be resumed as follows: 
 There are no relevant differences between values obtained from amplitude and 
resistance. This way the angle value is ignorable, and strange results in terms of the phase 
variation across frequencies are not relevant, especially since the ICG analysis is made at a 
single frequency. 
 The influence of sitting is not very clear on the results, but the values seem to be in 
general accordance to those in the literature either for sitting or for the reference interval. 
 The physiological variation of the studied parameters can justify some discrepancies 
between individual measurements. Nevertheless, for the same subject there are relevant and 
diverse alterations on the hemodynamic parameters across frequencies and also between 
configurations, which would not be naturally expected on healthy subjects. 
 The most relevant point related to the excitation frequency is the wave form, that in 
general seems more stable and literature looked-alike for 50 kHz. 
 The constant blood resistivity and the formula for obtaining the Qonset for PEP turn 
these values into estimations that should not be used for accurate physiological evaluation 
purposes. 
 For a question of signal fidelity and easier location of the electrode positioning spots 
the anteroposterior configuration seems the most appropriated. 
This studies also shown that the system needs to be improved at the hardware level, 
especially because of the ECG and ICG influence on each other. The impedance SNR would 
benefit from an improvement, which would probably open other signal processing options, but 
the small amplitude of the ICG signals imposes an intrinsic limitation. Also, the de-noising 
process by applying a strong filtering is not the most correct and the narrow pass band around 
the heart rate might have uncovered some interesting features. The signal analysis and 
processing was a very consuming process that could only be carried out with a small study 
population, for larger populations it would be mandatory to develop automatized algorithms. 
Both the lack of a reference process for the impedance measurement and for the 
physiological parameter calculation was limiting in terms of to the conclusions that could be 
assessed. 
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7.1. General conclusions 
The work developed during this project managed to study the Impedance 
Cardiography in many of its facets.  
The phantom set-up developed was more interesting for the purpose of 
understanding the impedance methods than to improve the present state of knowledge on the 
ICG area. The fact of being developed while the actual ICG system was not completely 
functional led to some improvisations that are not congruent with the actual ICG application. 
The major goal of this project was to develop a functional system for ICG 
acquisitions. The prototype including hardware, firmware and software was built and tested 
on real ICG acquisitions on volunteers, showing overall acceptable performance of the 
impedance unit - capable of discerning small impedance fluctuations related to the cardiac 
activity -, but also the necessity to improve the ECG acquisition method at the hardware level. 
Furthermore, a simplified non-automated offline signal analysis cascade was applied to the 
recovered ICG and ECG signals in order to obtain parameters of physiological relevance. The 
results were in average inside the reference intervals, showing general accordance between 
measurements, despite several approximations and deficiencies spotted in the system’s 
overall operation and the large percent errors associated with individual measurements. 
Though, the large uncertainties associated with the hemodynamic indicators, mostly related to 
the influence of the ECG on the impedance measurement, turns their use unreasonable to 
establish correct physiological correlations.  
The developed prototype is although far from providing an accurate monitoring of 
the physiological data and caresses from improvements before the system can be of clinical 
utility but contributes with a good knowledge base to future works. 
In general terms, the Impedance Cardiography proved to be an assessable method, 
but the accurate signal analysis seems to be an important challenge. Also, the limitation of the 
scientific basis in which the technic relies is an important weakness, but did not present any 
particular limitation to the developed work. 
 
7.2. Future work 
The correct and safe operation of the ICG acquisition system relies primarily on the 
hardware performance improvement. 
Even though the system proved to perform well on the required impedance range, 
the need to develop a test circuit based on the stray impedances model remains. That would 
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allow performing the adjustment of the calibration procedure in the ICG range. This also relies 
on the need to obtain a reference method to establish the impedance measurement 
comparison. 
The detected ECG/ICG crosstalk can be in part resolved by using an ECG circuit that 
does not grounds the patient - which proved to be the source of the ICG distortion -, 
connecting the right leg electrode to the output of an operational amplifier [99]. Also, such 
type of ECG system provides interference proof methods to improve the signal, relative to 
those that connect the subject ground to the ground of the system. The ICG system 
performance was superficially evaluated when acquiring the ECG with a third part developed 
system of such nature. The results showed no saturation of the ECG signal, only a slightly 
augmented noise level and the visual analysis of the impedance wave did not show any 
important alteration, although, this solution should be tested in more depth in relation to the 
ICG signal. 
Other small improvements very specific to the developed system would include: the 
electrodes driven-shield; the use of high pass filters on the AD8220 entries to perform the AC-
coupling of the residual bias-current, as shown in [71], which could improve the performance 
of the system with respect to the amplifier leakage current; improvement of the circuit that 
feeds 1.65 V to the instrumentation amplifier, to provide a stable reference, since the constant 
need to adjust its output would never be tolerated on a practical application. Also the AD5933 
sensing resolution would probably benefit from an increased internal gain, causing the 
impedance measurement range of the system to decrease. These improvements could not be 
implemented during the time of the project for time constraints. 
The signal analysis needs improved automated methods for signal processing, to 
eliminate possible affectations of the initial filtering and turn the remaining process more 
expeditious, in order to allow the beat-to-beat ICG analysis and the processing in real-time. 
While performing measurements on a human being it is not possible to tell apart the 
regular variations due to physiological events, from the errors introduced by the measurement 
device. This way, the final validation of the physiological parameters returned from the system 
depends on the comparison with the results of simultaneous acquisition with other 
hemodynamic probes. 
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Appendix A:  Reference Values for Thoracic 
Impedance 
The typical values of thoracic impedance were compiled from difference sources in 
the literature in order to serve as a reference for comparison, the results are presented in 
table 31. The interval of impedance values can be considered to incorporate good estimates 
for the accepted range of frequencies for ICG applications. 
 
Table 31) Thoracic impedance typical values: compilation from several sources. 
Parameter 
Interval of reference 
values 
References 
Base thoracic 
impedance (Z0) 
Male: 20 – 30 Ω 
Female: 25 – 35 Ω 
Biopac Systems, 2008 [94] 
 15 – 45 Ω Cybulski, 2011 [4] 
Brown et al., 1994 [100] 
Bernstein et al., 2010 [45] 
Base thoracic phase 
shift (Ɵ0) 
Male: 7.71 – 13.21° 
Female: 6.4 – 10.92° 
Baumgartner et al., 1988 [101] 
Cybulski, 2011 [4] 
Respiratory component 
amplitude (ΔZr)   
0.675 – 2.025 Ω Brown et al., 1994 [100] 
Lozano et al., 1990 [20] 
 
Cardiac component 
amplitude (ΔZc) 
0.04 – 0.4 Ω Brown et al., 1994 [100] 
Cybulski, 2011 [4] 
Lozano et al. 1990 [20] 
Bernstein et al., 2010 [45] 
Bronzino, 2006 [12] 
 
(dZ/dt)max 0.8 – 2.5 Ω/s Biopac Systems, 2008 [94] 
Bronzino, 2006 [12] 
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Appendix B:  Reference values for Hemodynamic 
Parameters 
The typical values for the hemodynamic parameters that can be determined by ICG’s 
signal analysis are presented in table 32. The hemodynamics tend to be affected by the body 
posture, that way its relevant to indicate the values in the reference position (supine) and 
those reported while sitting, to make a more accurate comparison with the results of the 
acquisitions during this project.  The heart rate is only indicated for completeness, since the 
values resulting from the signal analysis were directly compared with measurements on the 
subjects with an arm cuff. 
Table 32) Hemodynamic parameters reference values compilation [94, 102]  and interval of reported values while 
sitting [97, 98]. 
Parameter Interval of reference values 
Interval of reported 
values while sitting 
Heart Rate (HR) 60 – 100 bpm - 
Left Ventricular Ejection Time (LVET) 0.25 – 0.35 s 0.26 - 0.31 
Pre-ejection Period (PEP) 0.05 – 0.12 s 0.11 - 0.14 
Stroke Volume (SV) 60 - 100 mL/beat 74.5 - 142.7 
Cardiac Output (CO) 4 - 8 L/min - 
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Appendix C:  Circuit Schematics 
Impedance meter unit 
 
Figure 61) Signal conditioning circuit schematic. All the resistor values are in units of ohm (Ω) and the capacitors 
in farads (F). 
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Figure 62) AD8220 reference generation circuit. The resistors values are presented in units of ohm (Ω) and the 
capacitors values are in farad (F). 
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ECG commercial unit 
 
Figure 63) ECG front-end circuit scheme [82], directly extracted from the producers web page. The squares 
represent test points (T1, T2, T3). 
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Appendix D:  Current evaluation on board 
The evaluation of the current output presented on section 5.2 was extended and 
other tests were conducted based on the principles described there. The current after the 
blocking capacitor was studied based on an estimative of the total resistance in the current 
path equal to the load plus the grounded resistor value – also resulting in a systematic error 
for excess. 
 
 
Figure 64) PCB: Current amplitude through the path to the ground on the DC blocking capacitor output. 
 
The current amplitude is inside the safe range proposed for the ICG applications (<2.5 
mA as the most limitative value at 50 kHz, section 2.4.1). 
 
 
Mean (mA) -0.149 ± 0.006 
Maximum (mA) -0.069 
Minimum (mA) -0.227 
Figure 65) PCB: DC bias current through the path to the ground on the DC blocking capacitor output. 
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The DC bias results are below the human sensibility limit (<0.6 mA in module, section 
2.4.1). 
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Appendix E:  Calibration model fitting curves 
The calibration models were established as a result of a fitting procedure to obtain 
the description of the calibration parameters as a function of the raw amplitude. Those models 
were chosen based on the ratio of accuracy to complexity, avoiding the model over fitting to 
the train data. 
5
0
 k
H
z 
 
 
𝐺𝑎𝑖𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 50𝑘 = 1.130085758 × 10
−8 + 
6.69068314×10−8
𝑅𝑎𝑤𝐴𝑚𝑝
+  6.260232797 × 10−19 × 𝑅𝑎𝑤𝐴𝑚𝑝2 
7
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 k
H
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𝐺𝑎𝑖𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 70𝑘 =  1.135436885 × 10
−8  + 
9.978615398×10−8
𝑅𝑎𝑤𝐴𝑚𝑝
+  9.326520592 × 10−19 × 𝑅𝑎𝑤𝐴𝑚𝑝2 
1
0
0
 k
H
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𝐺𝑎𝑖𝑛 𝑓𝑎𝑐𝑡𝑜𝑟100𝑘 =  1.15178707511559 × 10
−8  +  
1.01313850600216 × 10−7
𝑅𝑎𝑤𝐴𝑚𝑝
 + 1.25312825545977 × 10−18 × 𝑅𝑎𝑤𝐴𝑚𝑝2 
Figure 66) Gain factor at 50, 70 and 100 kHz: fitting results from Eureqa mathematical software (left) and the 
relation between the real gain factor and the result from the model (right).The mathematical expression for each 
frequency is presented. 
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𝑆𝑦𝑠𝑡𝑒𝑚 𝑝ℎ𝑎𝑠𝑒 50𝑘 = 2.226742715 +  4.149126782 × 10
−6 × 𝑅𝑎𝑤𝐴𝑚𝑝 + 
5.883422813
𝑅𝑎𝑤𝐴𝑚𝑝
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𝑆𝑦𝑠𝑡𝑒𝑚 𝑝ℎ𝑎𝑠𝑒 70𝑘 =  2.488670251 +  5.860338713 × 10
−6 × 𝑅𝑎𝑤𝐴𝑚𝑝 + 
6.22902304
𝑅𝑎𝑤𝐴𝑚𝑝
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𝑆𝑦𝑠𝑡𝑒𝑚 𝑝ℎ𝑎𝑠𝑒 = 2.885163903 +  8.218149152 × 10−6 × 𝑅𝑎𝑤𝐴𝑚𝑝 + 
2.969428762
𝑅𝑎𝑤𝐴𝑚𝑝
 
Figure 67) System phase at 50, 70 and 100 kHz: fitting results from Eureqa mathematical software (left) and the 
relation between the real gain factor and the result from the mode (right).The mathematical model for each 
frequency is presented and are defined in radians. 
 
The results are defined and presented in radians, since the user interface performs 
calculations that way. 
The fitting results showed enough complexity to provide calibration parameters with 
overall accordance to the original ones, without overfitting the data. 
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Appendix F:  Uncertainties of the automated 
calibration procedure 
To study how a single pair of calibration values to correct a varying impedance would 
affect the results a few tests were carried out. The evaluation was made based on the mean, 
maximum and minimum non-calibrated amplitude of 2 sets of thoracic data at each of the 
working frequencies. The data was collected on subject # 3 (Chapter 6) using a configuration 
with two electrodes vertically aligned on the left side of the neck and other two on the left side 
of the thorax near the end of the rib cage, the outside electrodes applied the current while the 
inner electrodes sensed the voltage, as presented on [33]. This configuration was not used 
during the acquisitions. In this case the impedance was unknown, so the reference was the 
mean amplitude and phase calibrated by the parameters obtained from the model expressions 
(Appendix E) based on the mean raw amplitude of the whole acquisition. The analysis was 
then made in comparative terms. The mean, maximum and minimum designations related to 
the phase are only indicative, since they correspond to the mean, maximum and minimum raw 
amplitude. 
 
Table 33) Data set resume: average calibrated reference values from two data sets and standard error of the 
mean.  
Frequency 
(kHz) 
Amplitude (Ω) Phase (°) 
Mean 
Amplitude 
Maximum 
Amplitude 
Minimum 
Amplitude 
Mean phase Maximum 
phase 
Minimum phase 
50 44.207 ±0.393 45.157 ± 0.443 42.967 ± 0.121 -10.927 ± 0.106  -11.334 ± 0.122 -10.461 ± 0.068 
70 41.878 ±0.040 42.818 ±0.064 40.656 ± 0.331 -11.016 ± 0.087 -11.386 ± 0.064 -10.544 ± 0.166 
100 39.441 ±0.136 40.211 ± 0.190 38.703 ± 0.083 -10.752 ± 0.047 -11.063 ± 0.017 -10.432 ± 0.059 
 
First, by comparing the raw amplitude determined from the 10 s initial period to the 
raw data from the whole acquisition, was estimated that a 10 s period would determine the 
mean raw amplitude during the whole measurement with a maximum error of 2 %. The effect 
of the error propagation to the calibration factors and its influence on the final measurement 
was directly simulated by introducing a ± 2 % variation in the raw amplitude, calculating the 
resultant calibration parameters and using them to correct the mean raw amplitude and raw 
phase from the whole set of measurements. The absolute difference between the values in 
either case was still very small (table 34). 
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Table 34) Maximum discrepancy of the data calibrated using the simulated 10 second period influence of ±2% on 
the raw amplitude relative to the reference amplitude and phase. 
Maximum relative errors of the mean amplitude and phase 
Correction based on +2% Raw Amplitude Correction based on -2% Raw Amplitude 
Amplitude (Ω) Phase (°) Amplitude (Ω) Phase (°) 
0.0101 0.0052 0.0105 0.0056 
 
The maximum and minimum raw amplitude and raw phase values of each set where 
used to verify the effect of the constant correction value on the extremes, by first calculating 
the calibration parameters based on the raw amplitude on the extreme situations and using 
them to obtain the calibrated values and also simulating the ±2 % of the raw amplitude. These 
values were then compared to the ones obtained with the calibration values from the mean 
and from the variation of ±2 %. 
 
Table 35) Maximum discrepancy between the maximum raw values of the data set calibrated using maximum 
raw amplitude and those same values calibrated using the mean raw amplitude. Also the 10 second period 
influence of ±2% of the raw amplitude was simulated in both cases and compared. 
Maximum relative errors on the maximum amplitude and phase 
Correction based on +2% Raw 
Amplitude 
Correction based on -2% Raw 
Amplitude 
Correction based on Raw 
Amplitude 
Amplitude (Ω) Phase (°) Amplitude (Ω) Phase (°) Amplitude (Ω) Phase (°) 
0.0017 0.0008 0.0224 0.0112 0.0119 0.0058 
 
Table 36) Maximum discrepancy between the minimum raw values of the data set calibrated using minimum raw 
amplitude and those same values calibrated using the mean raw amplitude. Also the 10 second period influence 
of ±2% of the raw amplitude was simulated in both cases and compared. 
Maximum relative errors on the minimum amplitude and phase 
Correction based on +2% Raw 
Amplitude 
Correction based on -2% Raw 
Amplitude 
Correction based on mean Raw 
Amplitude 
Amplitude (Ω) Phase (°) Amplitude (Ω) Phase (°) Amplitude (Ω) Phase (°) 
0.0308 0.0168 0.0224 0.0109 0.0213 0.0118 
 
The conclusion from this analysis is that using a calibration based on the mean raw 
amplitude of a 10 s period has little influence over the values near the mean value around 
which the oscillation occurs and such abstraction does not show a significant difference from 
correcting the limit values with the calibration values deduced from the mean raw amplitude.  
 
Table 37) Maximum overall discrepancy detected by studding the effect of a single pair of calibration values 
based on a 10 second period. This table resumes the last three tables. 
Overall maximum discrepancy 
Amplitude (Ω) Phase (°) 
0.0308 0.0168 
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The evaluated errors are none the less small, being an order of magnitude inferior to 
the errors evaluated on the calibration procedure performance test with resistors. 
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Appendix G:  Relevant parameters from the signal analysis and respective 
uncertainties 
Table 38) Hemodynamic parameters and resume of relevant values for their calculation, with the associated uncertainties. 
Category Parameter Description Expression Uncertainty estimation 
Basic 
values 
L (cm) 
Distance between the 
sensing electrodes 
- ±1 
Z0’ (Ω) 
Mean thoracic 
impedance over the 
periods accepted for ICG 
averaging 
- Error associated with the system performance (section 5.3.2) 
ρ (Ω.cm) Blood resistivity Cte = 147 - 
Signal 
features 
Rt (s) R peak ordinate - 
𝛿𝛿𝛿𝛿𝑡𝑡 =
∑ 𝑆𝑆𝑡𝑡(𝑖𝑖) − 𝑄𝑄𝑡𝑡(𝑖𝑖)
𝑛𝑛−1
𝑖𝑖=1
2 × 𝑛𝑛
, S𝑡𝑡 and Qt are the ordinates of the S and Q ECG waves 
 
RR (s) 
Average R-R interval 
 𝛿𝛿𝛿𝛿 =
∑ 𝛿𝛿𝑡𝑡(𝑖𝑖 + 1) − 𝛿𝛿𝑡𝑡(𝑖𝑖)
𝑛𝑛−1
𝑖𝑖=1
𝑛𝑛
 𝛿𝛿𝛿𝛿𝛿𝛿 = standard error of the mean 
Bt (s) B point ordinate - 𝛿𝛿𝛿𝛿𝑡𝑡 =
𝛿𝛿𝐵𝐵𝑖𝑖𝑛𝑛𝑡𝑡(𝑖𝑖) − 𝐶𝐶𝑡𝑡(𝑖𝑖)
2
, Bmin is the local minimum before C. 
Xt (s) X point ordinate - 
 
𝛿𝛿𝛿𝛿𝑡𝑡 =
𝛿𝛿𝑡𝑡(𝑖𝑖) − 𝐶𝐶𝑡𝑡(𝑖𝑖)
3
 
(dz/dt)max  
(Ω/cm) 
C point abscissa - 𝛿𝛿(dz/dt)max =  standard error of the mean of ensemble averaged samples at Ct 
Rate HR (bpm) Heart rate 𝐻𝐻𝛿𝛿 =
60
𝛿𝛿𝛿𝛿 
 𝛿𝛿𝐻𝐻𝛿𝛿 =
60
𝛿𝛿𝛿𝛿2
𝛿𝛿𝛿𝛿𝛿𝛿 
Systolic 
Times 
PEP (s) Pre-ejection time 𝑃𝑃𝑃𝑃𝑃𝑃 = 𝛿𝛿𝑡𝑡 − 𝛿𝛿𝑡𝑡 + 0.048 𝛿𝛿𝑃𝑃𝑃𝑃𝑃𝑃 = √𝛿𝛿𝛿𝛿𝑡𝑡
2 + 𝛿𝛿𝛿𝛿𝑡𝑡
2 
LVET (s) 
Left ventricular ejection 
time 
𝐿𝐿𝐿𝐿𝑃𝑃𝐿𝐿 = 𝛿𝛿𝑡𝑡 − 𝛿𝛿𝑡𝑡  𝛿𝛿𝐿𝐿𝐿𝐿𝑃𝑃𝐿𝐿 = √𝛿𝛿𝛿𝛿𝑡𝑡
2 + 𝛿𝛿𝛿𝛿𝑡𝑡
2 
Cardiac 
volumes 
SV 
(mL/beat) 
Stroke volume 𝑆𝑆𝐿𝐿 = 𝜌𝜌 × (dz/dt)𝑚𝑚𝑚𝑚𝑚𝑚 × 𝐿𝐿𝐿𝐿𝑃𝑃𝐿𝐿 × (
𝐿𝐿
𝑍𝑍0′ 
)
2
 𝛿𝛿𝑆𝑆𝐿𝐿 = 𝜌𝜌
𝐿𝐿
𝑍𝑍0′2
√(𝐿𝐿𝐿𝐿𝑃𝑃𝐿𝐿 × 𝐿𝐿 × 𝛿𝛿(dz/dt)𝑚𝑚𝑚𝑚𝑚𝑚)
2 + ((dz/dt)𝑚𝑚𝑚𝑚𝑚𝑚 × 𝐿𝐿 × 𝛿𝛿𝐿𝐿𝐿𝐿𝑃𝑃𝐿𝐿)
2 + (2 × (dz/dt)𝑚𝑚𝑚𝑚𝑚𝑚 × 𝐿𝐿𝐿𝐿𝑃𝑃𝐿𝐿)
2 × (𝛿𝛿𝐿𝐿2 + (
𝐿𝐿
𝑍𝑍0′
𝛿𝛿𝑍𝑍0′)
2
) 
CO (L/min) Cardiac output 𝐶𝐶𝐶𝐶 = 𝑆𝑆𝐿𝐿 × 10−3 × 𝐻𝐻𝛿𝛿 𝛿𝛿𝐶𝐶𝐶𝐶 = √(𝐻𝐻𝛿𝛿 × 𝛿𝛿𝑆𝑆𝐿𝐿)2 + (𝑆𝑆𝐿𝐿 × 𝛿𝛿𝐻𝐻𝛿𝛿)2  × 10−3 
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Appendix H:  Impedance data resume from 
simultaneous acquisitions of impedance and ECG 
The data resume from the simultaneous acquisitions of impedance and ECG on 3 
subjects is presented, relative to the thoracic impedance, cardiac component and respiratory 
component. These results are under the influence of the ECG/ICG crosstalk. These values in 
general terms are near the ones obtained without the ECG simultaneous acquisitions, but 
present distinct influences as a function of the AC-current frequency and electrode 
configuration. For that reason were used only to evaluate the maximum error introduced by 
this crosstalk. 
 
Anteroposterior configuration 
Table 39) Thoracic impedance average (Z0) values obtained from two acquisitions at each frequency for the 
anteroposterior configuration. The uncertainties for the amplitude and phase are the constants determined on 
section 5.3.2, in the case of the real and imaginary values an error propagation was performed. 
# F (kHz) L (cm) |Z0| (Ω) Ɵ0 (°) RZ0 (Ω) XZ0 (Ω) 
1 50 25 ± 1 18.30 ± 1.38 -4.64 ± 1.88 18.24 ± 1.38 -1.48 ± 0.61 
100 17.48 ± 1.38 -7.65 ± 1.88 17.33 ± 1.37 -2.33 ± 0.60 
2 50 21 ± 1 15.47 ± 1.38 -4.21 ± 1.88 15.43 ± 1.38 -1.14 ± 0.52 
100 14.84 ± 1.38 -5.18 ± 1.88 14.78 ± 1.38 -1.34 ± 0.50 
3 50 24 ± 1 21.24 ± 1.38 -3.80 ± 1.88 21.20 ± 1.38 -1.41 ± 0.70 
100 20.17 ± 1.38 -5.27 ± 1.88 20.09 ± 1.38 -1.85 ± 0.67 
Average - 23 ± 1 17.92 ± 0.94 -5.13 ± 0.51 17.84 ± 0.94 -1.59 ± 0.16 
 
Table 40) Peak-to-peak values of the de-noised cardiac impedance component (ΔZc) obtained from the thoracic 
impedance signal for the anteroposterior configuration. The uncertainties were estimated from the standard 
error of the mean. 
# F (kHz) Δ|Zc|(Ω) ΔRZc (Ω) 
1 50 0.18 ± 0.01 0.18 ± 0.01 
100 0.18 ± 0.01 0.18 ± 0.01 
2 50 0.15 ± 0.01 0.15 ± 0.01 
100 0.13 ± 0.01 0.13 ± 0.01 
3 50 0.21 ± 0.01 0.21 ± 0.01 
100 0.16 ± 0.01 0.16 ± 0.01 
Average - 0.17 ± 0.01 0.17 ± 0.01 
% of the base value - 0.95 0.61 
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Table 41) Peak-to-peak values of the de-noised respiratory impedance component (ΔZr) obtained from the 
thoracic impedance waves for the anteroposterior configuration. The uncertainties were estimated from the 
standard error of the mean. 
# F (kHz) Δ|Zr|(Ω) ΔRZr (Ω) 
1 50 0.05 ± 0.02 0.05 ± 0.02 
100 0.06 ± 0.01 0.06 ± 0.01 
2 50 0.23 ± 0.03 0.23 ± 0.03 
100 0.19 ± 0.03 0.19 ± 0.03 
3 50 0.20 ± 0.02 0.16 ± 0.02 
100 0.22 ± 0.02 0.19 ± 0.03 
Average - 0.16 ± 0.03 0.15 ± 0.03 
% of the base value - 0.88 0.83 
 
Table 42) Values used to calculate the hemodynamic parameters from the anteroposterior configuration. 
# F (kHz) L (cm) N beats 
Z0’ (Ω) (dZ/dt)max (Ω/s) 
|Z| R |Z| R 
1 50 25 ± 1 61 18.29± 1.38 18.23 ± 1.43 1.82 ± 0.44 1.80 ± 0.43 
100 39 17.51 ± 1.38 17.36 ± 1.43 1.52 ± 0.44 1.49 ± 0.43 
2 50 21 ± 1 43 15.47 ± 1.38 15.43 ± 1.43 1.33 ± 0.44 1.31 ± 0.43 
100 14 14.92 ± 1.38 14.86 ± 1.43 1.43 ± 0.44 1.41 ± 0.43 
3 50 24 ± 1 50 21.25 ± 1.38 21.20 ± 1.43 2.75 ± 0.44 2.73 ± 0.43 
100 11 20.20 ± 1.38 20.12 ± 1.43 1.66 ± 0.44 1.63 ± 0.43 
Average - 23 ± 1 218 17.94 ± 0.94 17.86 ± 0.94 1.75 ± 0.19 1.73 ± 0.19 
 
Table 43) Hemodynamic parameters from the anteroposterior configuration. 
# F (kHz) 
HR 
(bpm) 
PEP (s) LVET (s) SV (ml/beat) CO (L/min) 
|Z| R |Z| R |Z| R |Z| R 
1 
50 
79.93 ± 
0.02 
0.13 
± 
0.07 
0.13 
± 
0.07 
0.28 
± 
0.09 
0.28 
± 
0.09 
139.49 ± 
60.09 
137.66 ± 
59.42 
11.15 
± 4.80 
11.00 
± 4.75 
100 
75.84 ± 
0.05 
0.11 
± 
0.09 
0.11 
± 
0.09 
0.31 
± 
0.10 
0.31 
± 
0.10 
138.95 ± 
66.85 
140.07 ± 
67.42 
10.54 
± 5.07 
10.62 
± 5.11 
2 
50 
68.28 ± 
0.05 
0.10 
± 
0.07 
0.10 
± 
0.07 
0.30 
± 
0.09 
0.30 
± 
0.09 
108.76 ± 
53.92 
108.68 ± 
53.75 
7.46 ± 
3.68 
7.46 ± 
3.67 
100 
70.07 ± 
0.04 
0.13 
± 
0.06 
0.13 
± 
0.06 
0.29 
± 
0.09 
0.29 
± 
0.09 
120.73 ± 
57.64 
119.60 ± 
57.20 
8.45 ± 
4.04 
8.37 ± 
4.01 
3 
50 
88.29 ± 
0.04 
0.11 
± 
0.06 
0.11 
± 
0.07 
0.25 
± 
0.08 
0.25 
± 
0.08 
130.96 ± 
49.77 
131.06 ± 
49.85 
11.56 
± 4.39 
11.57 
± 4.40 
100 
86.10 ± 
0.03 
0.09 
± 
0.08 
0.08 
± 
0.08 
0.31 
± 
0.10 
0.31 
± 
0.10 
105.12 ± 
46.39 
105.40 ± 
46.34 
9.05 ± 
3.99 
9.07 ± 
3.99 
Average 
78.09 ± 
3.06 
0.11 
± 
0.01 
0.11 
± 
0.01 
0.29 
± 
0.01 
0.29 
± 
0.01 
124.00 ± 
5.56 
123.74 ± 
5.51 
9.70 ± 
0.61 
9.68 ± 
0.61 
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The HR (table 43) is in accordance to the physiological acceptable values (60-100 
bpm). The individual variations from the initial direct HR measurement (table 21) that can be 
easily explained by assuming that during the long acquisition process this parameter naturally 
changed. The PEP value was sometimes higher than the reference values (0.05-0.12 s), but is 
always inside the interval of values while sitting (0.11-0.14 s). The LVET average value, as well 
as all the values from all subjects, is inside the reference interval (0.25-0.35 s).The SV is above 
the reference values (60-100 mL), but is always inside the estimated interval for 
measurements while sitting (74.5-142.7 mL). The CO is also augmented in accordance to the 
reference (4-8 L/min) but in average presents a close value, which is related to the SV value 
but also to the increased heart rate while sitting. 
 
Posterolateral configuration 
Table 44) Thoracic impedance average (Z0) values from the calibrated curves obtained from two acquisitions at 
each frequency for the posterolateral configuration. The uncertainties for the amplitude and phase are the 
constants determined on section 5.3.2, for the real and imaginary values an error propagation was made. 
# F (kHz) L (cm) |Z0| (Ω) Ɵ0 (°)  RZ0 (Ω) RZ0 (Ω) 
1 50 36 ± 1 29.88 ± 1.38 -6.95 ± 1.88  29.66 ± 1.37 -3.61 ± 0.99 
100 27.43 ± 1.38 -7.74 ± 1.88  27.18 ± 1.37 -3.70 ± 0.91 
2 50 30 ± 1 24.38 ± 1.38 -6.98 ± 1.88  24.20 ± 1.37 -2.96 ± 0.81 
100 23.43 ± 1.38 -4.89 ± 1.88  23.35 ± 1.38 -2.00 ± 0.78 
3 50 33 ± 1 29.86 ± 1.38 -5.70 ± 1.88  29.72 ± 1.38 -2.97 ± 0.98 
100 28.31 ± 1.38 -6.70 ± 1.88  28.11 ± 1.37 -3.31 ± 0.94 
Average - 33 ± 1 27.22 ± 1.02 -6.49 ± 0.38  27.04 ± 1.01 -3.09 ± 0.23 
  
Table 45) Peak-to-peak values of the de-noised cardiac impedance component (ΔZc) obtained from the thoracic 
impedance signal for the posterolateral configuration. The uncertainties were estimated from the standard error 
of the mean. 
# F (kHz) Δ|Zc|(Ω) ΔRZc (Ω) 
1 
50 0.16 ± 0.01 0.16 ± 0.01 
100 0.15 ± 0.01 0.15 ± 0.01 
2 
50 0.15 ± 0.01 0.15 ± 0.01 
100 0.13 ± 0.01 0.13 ± 0.01 
3 
50 0.20 ± 0.01 0.20 ± 0.01 
100 0.20 ± 0.01 0.19 ± 0.01 
Average - 0.17 ± 0.01 0.17 ± 0.01 
% of the base value - 0.61 0.61 
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Table 46) Peak-to-peak values of the de-noised respiratory impedance component (ΔZr) obtained from the 
thoracic impedance signal for the posterolateral configuration.  The uncertainties were estimated from the 
standard error of the mean. 
# F (kHz) Δ|Zr|(Ω) ΔRZr (Ω) 
1 50 0.18 ± 0.02 0.19 ± 0.03 
100 0.16 ± 0.03 0.16 ± 0.03 
2 50 0.21 ± 0.01 0.22 ± 0.01 
100 0.18 ± 0.06 0.18 ± 0.06 
3 50 0.47 ± 0.04 0.46 ± 0.06 
100 0.45 ± 0.05 0.43 ± 0.06 
Average - 0.28 ± 0.05 0.27 ± 0.05 
% of the base value - 1.02 1.00 
 
Table 47) Values used to calculate the hemodynamic parameters from the posterolateral configuration. 
# F (kHz) L (cm) N beats Z0’ (Ω) (dZ/dt)max (Ω/s) 
|Z| R |Z| R 
1 50 36 ± 1 49 29.87 ± 1.38 29.65 ± 1.43 1.55 ± 0.44 1.54 ± 0.43 
100 55 27.42 ± 1.38 27.17 ± 1.43 1.46 ± 0.44 1.45 ± 0.43 
2 50 30 ± 1 19 24.35 ± 1.38 24.17 ± 1.43 1.54 ± 0.44 1.52 ± 0.43 
100 27 23.35 ± 1.38 23.27 ± 1.43 1.30 ± 0.44 1.29 ± 0.43 
3 50 33 ± 1 25 29.88 ± 1.38 29.73 ± 1.43 2.43 ± 0.44 2.40 ± 0.43 
100 17 28.36 ± 1.38 28.17 ± 1.43 2.14 ± 0.44 2.11 ± 0.43 
Average - 33 ± 1 192 27.21 ± 1.04 27.03 ± 1.03 1.74 ± 0.16 1.72 ± 0.16 
 
Table 48) Hemodynamic parameters from the posterolateral configuration. 
# 
F  
(kHz) 
HR 
(bpm) 
PEP (s) LVET (s) SV (ml/beat) CO (L/min) 
|Z| R |Z| R |Z| R |Z| R 
1 
50 
87.01 
± 0.05 
0.12 ± 
0.07 
0.12 ± 
0.07 
0.27 ± 
0.09 
0.27 ± 
0.09 
88.10 ± 
39.32 
88.93 ± 
39.35 
7.67 ± 
3.42 
7.74 ± 
3.42 
100 
86.47 
± 0.03 
0.12 ± 
0.08 
0.12 ± 
0.08 
0.26 ± 
0.09 
0.26 ± 
0.09 
95.88 ± 
44.61 
97.12 ± 
45.01 
8.29 ± 
3.86 
8.40 ± 
3.89 
2 
50 
69.38 
± 0.04 
0.12 ± 
0.06 
0.12 ± 
0.06 
0.28 ± 
0.08 
0.28 ± 
0.08 
96.26 ± 
41.86 
96.93 ± 
42.08 
6.68 ± 
2.90 
6.73 ± 
2.92 
100 
70.73 
± 0.05 
0.11 ± 
0.08 
0.11 ± 
0.08 
0.29 ± 
0.09 
0.29 ± 
0.09 
92.46 ± 
44.70 
92.35 ± 
44.57 
6.54 ± 
3.16 
6.54 ± 
3.15 
3 
50 
88.54 
± 0.08 
0.10 ± 
0.06 
0.10 ± 
0.06 
0.26 ± 
0.08 
0.26 ± 
0.08 
112.28 
± 41.66 
112.78 
± 41.82 
9.94 ± 
3.69 
9.99 ± 
3.70 
100 
89.41 
± 0.07 
0.10 ± 
0.07 
0.10 ± 
0.07 
0.27 ± 
0.08 
0.27 ± 
0.08 
115.56 
± 44.95 
115.03 
± 44.62 
10.34 
± 4.02 
10.29 
± 3.99 
Average 
81.93 
± 3.45 
0.11 ± 
0.003 
0.11 ± 
0.003 
0.27 ± 
0.005 
0.27 ± 
0.005 
100.09 
± 4.16 
100.52 
± 4.03 
8.24 ± 
0.60 
8.28 ± 
0.59 
 
The heart rate (Table 48) between acquisitions (corresponding to different 
configurations) shows accordance for the same subject. The PEP average value shows no 
variation between configurations, a close analysis shows that all the values are inside the 
reference interval. The average LVET is smaller than the one determined for the first 
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configuration, but is still inside the reference interval. The SV and the CO are in average 
smaller than those for the first configuration being closer to the reference values. 
 
In both configurations the final values present high uncertainties mostly caused by 
the error propagation derived from the ECG/ICG crosstalk.
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Appendix I:  Averaged ICG waves 
The ensemble averaged ICG waves obtained from the simultaneous acquisition of 
impedance and ECG on 3 subjects are presented to illustrate the general influence of the 
excitation frequency and configuration on the final result. Only the impedance amplitude 
based waves are presented to avoid redundancy, since the resistance based curves shown the 
same information. The correspondent cardiac impedance and ECG waves were also averaged 
to use as visual reference and no parameters were derived from them after averaging. The 
signals present different total lengths since they were averaged for the minimum R-R period 
verified within the beat samples selected. 
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Figure 68) Averaged ICG waves based on the impedance amplitude, for different configurations and different 
frequencies of the excitatory AC current applied on subject #1. 
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Figure 69) Averaged ICG waves based on the impedance amplitude, for different configurations and different 
frequencies of the excitatory AC current applied on subject #2. 
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Figure 70) Averaged ICG waves based on the impedance amplitude, for different configurations and different 
frequencies of the excitatory AC current applied on subject #3. 
 
 
